NCT01008358
Anti-CTLA-4 Human Monoclonal Antibody CP-675,206 in Patients With Advanced Hepatocellular Carcinoma treatment 2 completed NCT00272389
Prediction of Response to Treatment of Patients With Chronic HCV Infection by Genetic Profile No drug interventions Not Available Not Available unknown_status NCT02216422
A Study to Evaluate Chronic Hepatitis C Virus (HCV) Infection in Cirrhotic Adults With Genotype 1b (GT1b) Infection treatment 3 completed NCT02640482
A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus (HCV) Genotype 2 Infection treatment 3 completed NCT02651194
A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Renally Impaired Adults With Chronic Hepatitis C Virus Genotype 1 - 6 Infection treatment 3 completed NCT01571583
An Efficacy and Safety Study of Telaprevir in Patients With Genotype 1 Hepatitis C Infection After Liver Transplantation treatment 3 completed NCT01159613
Do Low High Density Lipoprotein (HDL) Levels Predict Treatment Outcome in Patients With Chronic Hepatitis C Viral Infection? No drug interventions Not Available Not Available completed NCT06564051
Study to Assess Monoclonal B-Cell Lymphocytosis in Individuals With Chronic Hepatitis C No drug interventions Not Available Not Available enrolling_by_invitation NCT01889849
Comparative Pharmacokinetics and Pharmacodynamics of Peginterferon BIP48 and 40kDa in Healthy Volunteers treatment 1 completed NCT01164384
A Phase 1b, Single Center, Clinical Study to Investigate the Safety and Biological Responses to Baminercept in Patients With Chronic HCV Hepatitis. No drug interventions treatment 1 unknown_status NCT00351403
Individually Adapted Therapy Duration for the Treatment of Chronic Hepatitis C Genotype 1 Infection No drug interventions treatment 4 completed NCT02690103
Response Modifier (Arabinoxylan Rice Bran/MGN-3/Biobran) With Interferon-Alpha for HCV No drug interventions treatment 2 completed NCT02057003
Real-life Security and Efficacy of DAA-based Therapy in HCV/HIV-Coinfected Patients No drug interventions Not Available Not Available unknown_status NCT03987503
The No One Waits Study: Acceptability and Feasibility of Community-based Point-of-diagnosis HCV Treatment Study No drug interventions treatment 4 completed NCT02765490
Efficacy and Safety of Combinations of AL-335, Odalasvir (ODV) and Simeprevir (SMV) in the Treatment of Chronic Hepatitis C Infection No drug interventions treatment 2 completed NCT01364090
A Collaborative Trial in Injectors of Individualized Treatment for Genotype 2/3 No drug interventions treatment 4 completed NCT00689390
Three-year Follow-up of Participants After Administration of Boceprevir or Narlaprevir for the Treatment of Chronic Hepatitis C (P05063) No drug interventions other 2 / 3 terminated NCT01523990
A Study to Evaluate the Safety, Tolerability, and PK in Healthy Volunteers and HCV Genotype 1 Infected Patients No drug interventions treatment 1 completed NCT01425190
Pharmacokinetics of Boceprevir in Pediatric Subjects With Chronic Hepatitis C Genotype 1 (P07614) No drug interventions treatment 1 terminated NCT01358864
Efficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-Experienced Genotype 1 Hepatitis C Infected Patients (STARTverso 3) No drug interventions treatment 3 completed NCT00529321
Immunotherapy With TG4040 in Treatment-naïve Patients Chronically Infected With Hepatitis C Virus No drug interventions treatment 1 completed NCT00998621
ADHEPTA Study: Adherence Questionnaire in Hepatitis C No drug interventions Not Available Not Available completed NCT03772002
Hepatitis C Surveillance With Linkage to Care of Patients From Non-ID Departments in Jiangsu No drug interventions screening Not Available unknown_status NCT03551002
Impact of DAA Uptake in Controlling HCV Epidemic and Modeling Interventions for HCV Elimination Among HIV-infected Persons in San Diego No drug interventions Not Available Not Available unknown_status NCT01884402
Observational,Prospective Study to Develop and Validate a Prognostic Tool to Optimize Therapy in Patients With HCV G1/4 No drug interventions Not Available Not Available completed NCT03164902
Digimeds to Optimize Adherence in Patients With Hepatitis C and Increased Risk for Nonadherence No drug interventions treatment Not Available unknown_status NCT03200379
Nation-wide Hepatitis C Virus (HCV) Registry in Taiwan No drug interventions Not Available Not Available recruiting NCT00723879
Adherence in Patients Receiving PegIntron and Rebetol for Hepatitis C in Conjunction With a Patient Assistance Program (Study P04206) No drug interventions Not Available Not Available terminated NCT02641379
A Study of Peginterferon Alfa-2a (Pegasys) When Administered in Combination With Ribavirin in Patients With Chronic Hepatitis C (CHC) No drug interventions treatment 4 completed NCT04014179
Enhancing Hepatitis C Testing and Treatment Among People Who Inject Drugs Attending Needle and Syringe Programs No drug interventions health_services_research Not Available recruiting NCT00087633
PHOENIX Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) and COPEGUS (Ribavirin) Administered After Liver Transplantation for Hepatitis C. treatment 4 completed NCT01112033
Biliverdin Reductase A in Chronic Hepatitis C Virus Infection No drug interventions Not Available Not Available completed NCT03235154
A Pilot Study of Treating HCV at a Psychiatrist-staffed Outpatient Addiction Clinic treatment 4 completed NCT01001754
Efficacy and Safety Study of PEG-rIL-29 Plus Ribavirin to Treat Chronic Hepatitis C Virus Infection treatment 2 unknown_status NCT01903954
A Study of Setrobuvir in Combination With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) in Patients With Genotype 1 Chronic Hepatitis C treatment 2 completed NCT00724451
Observational Study Assessing Chronic Hepatitis C Management in Clinical Practice in Italy (Study P05488 AM1) Not Available Not Available completed NCT03018353
Curing HCV in Incarcerated Patients treatment 4 unknown_status NCT00127777
Peginterferon Alfa-2a, Ribavirin, Amantadine/Placebo in Hepatitis C Virus (HCV)-Genotype-1-Infection (PRAMA) treatment 4 unknown_status NCT00394277
A Study of Induction Dosing With PEGASYS (Peginterferon Alfa-2a [40KD]) Plus Copegus in Treatment-Naive Patients With Chronic Hepatitis C treatment 4 completed NCT00727077
Post-marketing Surveillance of Children With Chronic Hepatitis C Treated With Intron A (Vial or Pen) and Rebetol (Study P04397)(TERMINATED) Not Available Not Available terminated NCT01928147
A Phase 1a/1b Study of PPI-383 in Healthy Adults and Hepatitis C Patients No drug interventions treatment 1 completed NCT00192647
A Study of Induction Dosing With Peginterferon Alfa-2a and Ribavirin in Participants With Chronic Hepatitis C (CHC) Genotype 1 Infection treatment 4 completed NCT01220947
A Study of Danoprevir Boosted With Low Dose Ritonavir in Combination With Pegasys and Copegus in Treatment-Naive Patients With Chronic Hepatitis C Virus Infection treatment 2 completed NCT03764345
Eight Weeks Sofosbovir/Ledipasvir in HCV Infected Children Aged 4 to 10 Years No drug interventions treatment Not Available completed NCT00797745
A Pharmacokinetics/Pharmacodynamics Study of SCH 900518 in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C (Protocol No. P05104AM2)(COMPLETED) treatment 2 completed NCT00035945
ISIS 14803-CS2, Treatment With ISIS 14803, Administered IV in Patients With Chronic Hepatitis C Virus Infections treatment 2 completed NCT01850745
Multidisciplinary Support Program in Chronic Hepatitis C No drug interventions Not Available Not Available completed NCT00055445
IdB 1016 Treatment for Hepatitis C Disease No drug interventions treatment 1 / 2 completed NCT00389298
A Proof-of-concept Study of VCH-759 for the Treatment of Hepatitis C-infection. No drug interventions treatment 1 / 2 completed NCT00704405
Safety and Efficacy of Vaniprevir (MK-7009) With Pegylated Interferon (Peg-IFN) and Ribavirin (RBV) in Treatment-Experienced Hepatitis C Virus (HCV) Participants (MK-7009-009) treatment 2 completed NCT02771405
Impact of Interferon Free Regimens in Patients With Chronic HCV and Successfully Treated HCC treatment 3 unknown_status NCT02660905
HIV Drug Switch Followed by HCV Therapy in HIV-HCV Co-Infection treatment 3 completed NCT01226797
Safety And Efficacy Of Oral PF-4136309 In Patients With Chronic Hepatitis C Infection And Abnormal Liver Enzymes treatment 2 terminated NCT01098097
Post Marketing Observational Study of Retreatment of Chronic Hepatitis C With Peginterferon Alpha and Ribavirin (Study P06011) Not Available Not Available completed NCT00305383
Viral Kinetic Study With Viramidine in Therapy-Naive Patients With Chronic Hepatitis C treatment 2 terminated NCT00943761
A Study of Vaniprevir (MK-7009) in Participants With Chronic Hepatitis C Infection After Participation in Other Vaniprevir Studies (MK-7009-028) treatment 2 completed NCT01858961
Open Label Trial to Compare BI 207127 to Telaprevir in HCV Patients treatment 3 withdrawn NCT00375661
Low-dose Peg-interferon Plus Ribavirin (IFN/RBV) for Prevention of Hepatocellular Carcinoma (HCC) Recurrence in Patients Who Had Surgery to Remove Primary HCC prevention 4 completed NCT03342261
Benefit of DAA Therapy in HCV Monoinfected and HIV-HCV Coinfected Patients With Mixed Cryoglobulinemia No drug interventions Not Available Not Available completed NCT00623428
A Study of Combination Therapy With PEGASYS (Pegylated Interferon Alfa-2a (40KD)) and Copegus (Ribavirin) in Patients With Chronic Hepatitis C Genotype 2 or 3 Who Do Not Achieve a Rapid Viral Response treatment 3 completed NCT02262728
An Efficacy, Safety and Pharmacokinetics Study of Simeprevir, Daclatasvir and Sofosbuvir in Participants With Chronic Hepatitis C Virus Genotype 1 or 4 Infection and Decompensated Liver Disease treatment 2 completed NCT01353911
Grazoprevir (MK-5172) Administered With Peginterferon and Ribavirin in Treatment-Naïve Participants With Chronic Hepatitis C (MK-5172-003) treatment 2 completed NCT00793793
Safety, Antiviral Activity and PK of MRD of BI 201335 in Chronic Hepatitis C Patients Both Treatment Naive and -Experienced treatment 1 completed NCT00473993
Hepatitis C Among Opioid Addicts in Opioid Maintenance Treatment in Zurich, Switzerland No drug interventions Not Available Not Available completed NCT00039871
PEG-Intron Plus Rebetol Treatment of Chronic Hepatitis C Subjects Who Failed Response to Alpha-Interferon Plus Ribavirin (Study P02370) treatment 3 completed NCT01636778
Japanese Phase II Study of SB-497115-GR in Hepatitis C Virus Infected Patients treatment 2 completed NCT01329978
Sofosbuvir With Pegylated Interferon and Ribavirin Hepatitis C Virus (HCV) Genotypes 1,4,5,6 treatment 2 completed NCT04774107
The Pharmacokinetics of P1101 + Ribavirin in Interferon Treatment-Naïve Subjects With Chronic Hepatitis C Virus (HCV) Genotype 2 Infection other 1 completed NCT04952207
Effectiveness and Safety of Direct-Acting Antiviral Agents for the Treatment of Chronic Hepatitis C Not Available Not Available unknown_status NCT02254707
Evaluation of the Antiviral Pharmacodynamic Effect, Safety, and Pharmacokinetics of Escalating Doses of BILB 1941 ZW to Patients With Chronic Hepatitis C Genotype 1 Virus Infection No drug interventions treatment 1 / 2 completed NCT01147107
Hepatic Safety of Raltegravir Versus Efavirenz as HIV Therapy for Patients With HIV and HCV Coinfection treatment 4 completed NCT02541409
Directly Observed Therapy for HCV in Chennai, India treatment 2 completed NCT00803309
Study to Assess the Efficacy of 12 Versus 24 Weeks of Extended Treatment in HCV-Genotype 2/3 Patients treatment 4 terminated NCT03226509
Transforming the Cascade Of Hepatitis C Care No drug interventions Not Available Not Available completed NCT00863109
Quality of Life During Treatment of Chronic Hepatitis C (P05278/MK-4031-336) Not Available Not Available completed NCT01818856
Pharmacokinetic Interactions Between Telaprevir and Un-boosted Atazanavir treatment 1 completed NCT01508156
Study of Hepatitis C Virus (HCV) Nonstructural Protein 5a (NS5A) Inhibitor IDX719 in Healthy and HCV-Infected Participants (MK-1894-001) No drug interventions treatment 1 / 2 completed NCT02639585
Efficacy and Safety of Daclatasvir Plus Asunaprevir in Chronic Hepatitis C treatment 4 unknown_status NCT03903185
Pharmacokinetics of Ledipasvir/Sofosbuvir in Hepatitis C Virus-Infected Children With Hematological Malignancy treatment 1 / 2 completed NCT02498015
A Phase IV Trial of Paritaprevir/Ritonavir, Ombitasvir, Dasabuvir for Chronic Hepatitis C Genotype 1 Virus Infection treatment 4 completed NCT05542615
Prolonged Release Pirfenidone for Advanced Residual Liver Fibrosis (MINERVA). treatment 2 recruiting NCT00561015
A Phase 2a Study to Evaluate Viral Kinetics and Safety of Telaprevir in Participants With Genotype 2 or 3 Hepatitis C Infection treatment 2 completed NCT00399815
Noninvasive Evaluation of Hepatic Fibrosis in Chronic Hepatitis C No drug interventions Not Available Not Available unknown_status NCT01405937
Study of Vaniprevir Plus PegIntron®/Ribavirin in Japanese Participants With Chronic Hepatitis C Who Relapsed After Treatment (MK-7009-044) treatment 3 completed NCT01316237
A Study Evaluating the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of GS-6620 in Treatment Naïve Subjects With Chronic Hepatitis C Virus Infection Not Available 1 completed NCT03480932
Role of Pegylated Interferon in Combination With DAAs to Cure Hepatitis C As Soon As Possible - Hepatitis C [ASAP-C] treatment 2 / 3 completed NCT00905632
4 Week Combination of BI 207127 NA With Peg-IFN and Ribavirin in Chronic HCV Patients treatment 1 completed NCT00705432
Safety and Efficacy of Boceprevir in Previously Untreated Subjects With Chronic Hepatitis C Genotype 1 (Study P05216AM2) (COMPLETED) treatment 3 completed NCT00708500
Boceprevir in Subjects With Chronic Hepatitis C Genotype 1 Who Failed Prior Treatment With Peginterferon/Ribavirin (Study P05101AM3)(COMPLETED) treatment 3 completed NCT00423800
Efficacy and Safety of 24 vs 48 Weeks of Pegetron® (Peginterferon Alfa-2b + Ribavirin) in Naïve Genotype 1 Hepatitis C (Study P05016)(TERMINATED) treatment 3 terminated NCT01448200
A Phase 1 Study of PPI-668 in Healthy Volunteers and Patients With Hepatitis C Virus (HCV) Genotype 1 treatment 1 completed NCT01888900
New Treatment Response in People With and Without Cirrhosis From Chronic Hepatitis C No drug interventions treatment 2 completed NCT00727259
Evaluation of Satisfaction in Patients Receiving PegIntron Pen/Rebetol for Hepatitis C (Study P04067) Not Available Not Available completed NCT00709059
Efficacy of PegIntron and Rebetol in Previously Untreated Patients With Chronic Hepatitis C Infected With HCV Genotype 1/4/5/6 (Study P04243) Not Available Not Available completed NCT01062659
Cellular Immune Responses in the Liver in Chronic Hepatitis C (CHC) Patients No drug interventions Not Available Not Available withdrawn NCT01337375
A Study of the Pharmacokinetics And Pharmacodynamics of Intravenously Administered Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis C And Previous Non-Response to Pegylated Interferon And Ribavirin Combination Therapy treatment 1 completed NCT01841775
Interferon α 2b Pharmacovigilance Study treatment 4 completed NCT05904470
A Phase 2, Safety and Efficacy of Bemnifosbuvir (BEM) and Ruzasvir (RZR) in Subjects With Chronic HCV treatment 2 active_not_recruiting NCT01392742
An Observational Study on Predictive Factors of Response in Patients With Chronic Hepatitis C Treated With Pegasys (Peginterferon Alfa-2a) and Ribavirin No drug interventions Not Available Not Available completed NCT01370642
Vaniprevir Administered With Pegylated-interferon and Ribavirin in Japanese Treatment-Naïve Chronic Hepatitis C Participants (MK-7009-043) treatment 3 completed NCT03207399
Lung Transplantation in Chronic HCV Infection With Post Transplant EPCLUSA Treatment treatment 4 terminated NCT00110799
SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Thrombocytopenia Due To Hepatitis C treatment 2 completed NCT01609049
An Observational Study of Peginterferon Alfa-2a in Combination With Ribavirin in Participants With Chronic Hepatitis C and Compensated Liver Cirrhosis Not Available Not Available completed NCT00077649
A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C Infection (CHC). treatment 4 completed NCT05401136
Evaluating the Chain of Addiction Care (CAC) No drug interventions Not Available Not Available unknown_status NCT01132313
Safety, Antiviral Effect and PK of BI 207127 + BI 201335 +/- RBV for 4 up to 40 Weeks in Patients With Chronic HCV Genotype 1 Infection treatment 2 completed NCT02439918
Epidemic History and Iatrogenic Transmission of Blood-borne Viruses in Mid-20th Century Kinshasa No drug interventions Not Available Not Available completed NCT00353418
A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Genotype 1 and Human Immunodeficiency Virus-1 (HIV-1) Co-infection treatment 4 completed NCT00695019
Interferon-alpha Lozenges for Prevention of Relapse in Hepatitis C treatment 2 completed NCT01399619
Phase III Trial of BI 201335 (Faldaprevir) in Treatment Naive (TN) and Relapser Hepatitis C Virus (HCV)-Human Immunodeficiency Virus (HIV) Coinfected Patients (STARTverso 4) treatment 3 completed NCT00687219
Efficacy and Safety of Peginterferon Alfa-2b and Ribavirin Therapy in Subjects With Type C Compensated Liver Cirrhosis (Study P05116) treatment 3 completed NCT05140941
Sofosbuvir/Velpatasvir Treatment of Chronic Hepatitis C During Pregnancy treatment 4 recruiting NCT04019717
Study of AT-527 in Combination With Daclatasvir in Subjects With Hepatitis C Virus (HCV) Infection treatment 2 completed NCT04309734
Study of AT-777 in Healthy Subjects and AT-777 in Combination With AT-527 in HCV-Infected Subjects treatment 1 / 2 withdrawn NCT00412334
SYREN Study: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Copegus (Ribavirin) in Non-Responder Patients With Chronic Hepatitis C (CHC) Genotype 1. treatment 4 completed NCT00157534
A Study to Evaluate the Safety and Efficacy of Celgosivir in Patients With Chronic Hepatitis C Genotype 1 Infection treatment 2 completed NCT01728324
Phase 3 Study of BI 207127 in Combination With Faldaprevir and Ribavirin for Treatment of Patients With Hepatitis C Infection, Including Patients Who Are Not Eligible to Receive Peginterferon: HCVerso2 treatment 3 completed NCT01907724
Drug-Drug Interaction Between IDX719, Simeprevir, TMC647055 and Ritonavir When Administered in Combination in Healthy Participants (MK-1894-007) treatment 1 completed NCT00910624
Boceprevir Treatment in Participants With Chronic Hepatitis C Genotype 1 Deemed Nonresponders to Peginterferon/Ribavirin (P05514) treatment 3 completed NCT02027116
Phase I Trial to Evaluate the Safety, Tolerability and Immunogenicity of VGX-6150 for Second-line Therapy of Chronic Hepatitis C Infection No drug interventions treatment 1 completed NCT01500616
Telaprevir Open-Label Study in Co-Infected Patients treatment 3 completed NCT01750216
An Observational Study of Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) on Predictive Values of RVR on Sustained Virological Response in Different Stages of Liver Fibrosis in Treatment-Naïve Patients With Chronic Hepatitis C Genotype 1 No drug interventions Not Available Not Available completed NCT03513796
Evaluation of Multiple HCV Diagnosis Pathways for Efficacy, Cost Effectiveness and Cure in NHS Tayside No drug interventions Not Available Not Available completed NCT01081158
Safety, Tolerability, PK and PD of SCH 900518 in Naive or Treatment-Experienced Subjects Infected With HCV Genotype 1 (Protocol No. P04695) treatment 1 completed NCT04070235
SH229 Tablets Combined With Daclatasvir Dihydrochloride Tablets in Treatment Adult Patients With Chronic Hepatitis C treatment 2 / 3 unknown_status NCT01023035
Boceprevir/Peginterferon/Ribavirin for Chronic Hepatitis C: Erythropoietin Use Versus Ribavirin Dose Reduction for Anemia (P06086 AM2) treatment 3 completed NCT00148863
Interferon Gamma With Peg-Interferon Alpha 2a and Ribavirin in Non Responders Patients With Chronic Hepatitis C treatment 2 completed NCT02309086
Phase I-II Vaccination of Autologous Dendritic Cells Transduced With Adenoviral Vector Encoding NS3 in Hepatitis C Encoding NS3 in Hepatitis C No drug interventions treatment 1 / 2 terminated NCT01587586
Dose Finding Study of Pegylated-P-Interferon-alpha-2b(P1101) in Treatment-Naive Subjects With Hepatitis C Virus Genotype 1 Infection treatment 2 completed NCT01900886
Epidemiological Study to Evaluate Personality Disorders in Prison Populations in Treatment for Hepatitis C Not Available Not Available unknown_status NCT02804386
Efficacy and Safety of Zoval (Sofosbuvir) and Ribavirin With or Without Interferon treatment 4 completed NCT01994486
Open-Label Safety Study of Telaprevir and Sofosbuvir in Chronic Hepatitis C Genotype 1 treatment 2 completed NCT00565539
Study of PEG-rIL-29 (or PEG-IFN Lambda) in Subjects With Chronic Hepatitis C Virus Infection No drug interventions treatment 1 completed NCT01292239
A Phase III Study of TMC435 in Treatment-naive, Genotype 1, Hepatitis C-infected Patients treatment 3 completed NCT00517439
A Study of Hepatitis C Virus (HCV) Polymerase Inhibitor Pro-Drug in Combination With PEGASYS Plus COPEGUS Compared With PEGASYS Plus COPEGUS in Patients With Chronic Hepatitis C Genotype 1 Infection. treatment 2 completed NCT02726022
A Quality of Life Study of Peginterferon-Alfa-2a Plus Ribavirin in Participants With Chronic Hepatitis C and Persistently Normal Alanine Transaminase (ALT) Levels Not Available Not Available completed NCT03119025
Autologous Dendritic Cell Vaccine for Treatment of Patients With Chronic HCV-Infection No drug interventions treatment 1 / 2 completed NCT03343925
Direct-acting Antiviral Therapy and Reinfection Among PWID With Chronic HCV in Community-based Settings No drug interventions Not Available Not Available completed NCT01938625
A Study of Pharmacokinetics, Efficacy, Safety, Tolerability, of the Combination of Simeprevir (TMC435), Daclatasvir (BMS-790052), and Ribavirin (RBV) in Patients With Recurrent Chronic Hepatitis C Genotype 1b Infection After Orthotopic Liver Transplantation treatment 2 completed NCT01335230
The Study of Gut Associated Lymphocytes in HIV and HCV/HIV Co-infected Patients No drug interventions Not Available Not Available completed NCT01353248
GS 5885 Administered Concomitantly With GS-9451, Tegobuvir and Ribavirin (RBV) in Chronic Genotype 1 Hepatitis C Virus (HCV) Infection treatment 2 completed NCT00800748
A Study of Combination Treatment With Peginterferon Alfa-2a (Pegasys) Plus Ribavirin (Copegus) in Participants With Chronic Hepatitis C treatment 4 completed NCT00705666
Treatment of Patients With Chronic Hepatitis C With PegIntron as Monotherapy or in Combination With Ribavirin (Study P04437)(COMPLETED) Not Available Not Available completed NCT03797066
ATTIC - Access To Treat in the Community treatment 4 terminated NCT02292966
Impact of HCV Treatment on Neurocognitive Functions and Brain Metabolism treatment 4 withdrawn NCT00845065
Boceprevir in Combination With Peginterferon Alfa-2a and Ribavirin in Participants With Chronic Hepatitis C Genotype 1 Who Failed Prior Treatment With Peginterferon/Ribavirin (Study P05685AM2)(COMPLETED) treatment 3 completed NCT03186365
8 Weeks Versus 12 Weeks of Elbasvir/Grazoprevir in Treatment-naïve CHC With Mild Fibrosis treatment 3 completed NCT02120274
Vitamin D and Vitamin B12 Supplementation With Pegylated Interferon-Alfa Plus Ribavirin for Treating Chronic Hepatitis C treatment 4 terminated NCT00948220
Influence of Antiviral Therapy on Bone Mineral Density and Metabolism in Patients With Chronic Hepatitis C basic_science 4 completed NCT00724620
PEG-IFN Alfa-2b Plus Ribavirin for Treatment of Mexican naïve Patients With Chronic Hepatitis C Infected With Genotype 1 (Study P04511)(COMPLETED) treatment 4 completed NCT02601820
The Patient-Reported Outcomes Project of HCV-TARGET No drug interventions Not Available Not Available completed NCT01805882
Combination Therapy for Chronic Hepatitis C Infection treatment 2 completed NCT03880682
Direct Acting Antivirals for HCV Infection in Kidney Transplant Recipients No drug interventions Not Available Not Available completed NCT00377182
A Study of Hepatitis C Virus (HCV) Polymerase Inhibitor Pro-Drug in Combination With PEGASYS With or Without COPEGUS in Patients With Chronic Hepatitis C (CHC) Genotype 1 Infection. treatment 2 completed NCT00495131
Randomized Trial of 24 or 48 Weeks of Peginterferon Alfa-2a Plus Ribavirin for HCV Genotype 1-infected Patients treatment 4 completed NCT00724373
Study of HCV Genotype 1 Patients in the UK Treated With ViraferonPeg and Rebetol (Study P05269)(COMPLETED) Not Available Not Available completed NCT01439373
Safety, Antiviral Activity, and Pharmacokinetics of GSK2336805 With Peginterferon and Ribavirin in Chronic Hepatitis C Subjects treatment 2 completed NCT00040027
Thymosin Plus PEG-Interferon in Non-Cirrhotic Hepatitis C Patients Who Did Not Respond to Interferon or Interferon Plus Ribavirin treatment 3 completed NCT01675427
A Study on the Correlation Between Interleukin 28B Genotypes With Clinical and Demographic Characteristics in Treatment-Naïve and Treatment-Experienced Patients With Chronic Hepatitis C No drug interventions Not Available 4 completed NCT00996476
A Study to Assess the Effectiveness, Safety, and Pharmacokinetics of TMC435 in Combination With Peginterferon Alfa-2a and Ribavirin in Hepatitis-C Infected Patients treatment 2 completed NCT01908660
Hepatic Safety of Currently Used Antiretroviral Regimens in Patients With Chronic Hepatitis Under Real Life Conditions No drug interventions Not Available Not Available completed NCT01591460
A Triple Combination Therapy Study of Boceprevir, Pegasys and Copegus in Previously Untreated Patients With Genotype 1 Chronic Hepatitis C treatment 4 completed NCT01185860
A Study of Ritonavir-Boosted Danoprevir (RO5190591) in Combination With Pegasys and Ribavirin in Patients With Chronic Hepatitis C Genotype 1 treatment 1 completed NCT03520660
People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents treatment 4 active_not_recruiting NCT01356160
GS-5885 Alone or in Combination With GS-9451 With Peginterferon Alfa 2a and Ribavirin in Treatment Chronic Genotype 1 Hepatitis C Virus treatment 2 completed NCT01405560
Vaniprevir Plus PegIntron®/Ribavirin in Japanese Participants With Chronic Hepatitis C Who Are Non-responders to Previous Treatment (MK-7009-045) treatment 3 completed NCT00135694
Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver Transplant treatment 2 completed NCT01945294
Short Duration Versus Standard Response-Guided Therapy With Boceprevir Combined With PegIntron and Ribavirin in Previously Untreated Non-Cirrhotic Asian Participants With Chronic HCV Genotype 1 (MK-3034-107) treatment 3 completed NCT01628094
ANNAPURNA: A Study of The Combination of RO5466731, RO5190591, Ritonavir and Copegus (Ribavirin) With or Without RO5024048 in Patients With Chronic Hepatitis C Who Are Either Treatment-Naïve or Have Previously Experienced a Null Response to Interferon-Based Treatment treatment 2 completed NCT00087594
A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Copegus (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Enrolled in a Methadone Maintenance Treatment Program. treatment 4 completed NCT01604291
An Observational Study of Dual and Triple Therapies Based on Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis C No drug interventions Not Available Not Available completed NCT01579162
Intra-Individual Reproducibility of the Non-Invasive Assessment of the Portal Circulation No drug interventions diagnostic Not Available completed NCT04610762
HCV RNA Fingerstick Assay as Useful Point of Care of Diagnostic Tool for Drug Users in Brussels No drug interventions Not Available Not Available completed NCT02340962
Evaluate the Efficacy and Safety of TG-2349 in Subjects With Hepatitis C Infection treatment 2 completed NCT01879462
A First Time in Human Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single & Repeat Escalating Doses of GSK2878175 in Healthy Subjects No drug interventions treatment 1 completed NCT01871662
Randomized Study for the Assessment of Silibinin (Legalon® SIL) in the Treatment of naïve Genotype 4 Patients With Chronic Hepatitis C treatment 2 / 3 withdrawn NCT02858180
Hepatitis C Virus(HCV) Heart and Lung Study treatment 4 completed NCT00122629
Triple Therapy With Peg-Interferon Alfa-2b/Ribavirin Plus Amantadine Compared to Standard Peg-Interferon Alfa-2b/Ribavirin for Previous Hepatitis C Virus (HCV) Non Responders treatment 3 terminated NCT03888729
Simplifying HCV Treatment in Rwanda for Elsewhere in the Developing World: Pangenotypic and Retreatment Study (SHARED3) treatment 4 unknown_status NCT01725529
An Efficacy, Pharmacokinetics, Safety and Tolerability Study of TMC435 as Part of a Treatment Regimen for Hepatitis C-Infected Patients treatment 3 completed NCT01554189
A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of MK-8325 in Hepatitis C-Infected Males (MK-8325-002) No drug interventions treatment 1 terminated NCT03149289
Hepatitis C Virus Infection in Patients With Hemoglobinopathies No drug interventions Not Available Not Available completed NCT00953589
480 STUDY: Phase 2b Study of Locteron Plus Ribavirin to Treat Hepatitis C Virus (HCV) treatment 2 completed NCT01344889
An Observational Study on The Prediction of Adverse Events in Patients With Chronic Hepatitis C Receiving a Long-Acting Interferon Plus Ribavirin (GUARD-C) No drug interventions Not Available Not Available completed NCT01463592
To Study the Efficacy and Safety of Renessans in Chronic HCV Patients treatment 3 unknown_status NCT01429792
A Study Evaluating Slow Response/Non-Rapid Response in Patients With Chronic Hepatitis C, Genotype 1, 2, 3 & 4 Treated With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) treatment 4 completed NCT03551444
Recurrence Rate of Hepatocellular Carcinoma After Treatment of Chronic Hepatits C Patients With Direct Acting Antivirals: Randomized Controlled Phase 3 Trial No drug interventions treatment 3 unknown_status NCT00687544
Efficacy and Safety of PegIntron Plus Ribavirin for Treatment of Chronic Hepatitis C in HIV-Infected Subjects (Study P04469)(TERMINATED) treatment 4 terminated NCT03578640
Eight Weeks of Elbasvir/Grazoprevir in the Treatment of HCV Genotype 4 treatment 3 completed NCT01648140
Dose Ranging of GSK2336805 in Combination Therapy treatment 2 completed NCT01659567
A Study of Predictors of the Effectiveness of Pegylated Interferon in a Cohort of Participants With Hepatitis C Not Available Not Available completed NCT01057667
A Study of RO5024048 in Combination With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) in Patients With Chronic Hepatitis C Genotype 1 or 4 treatment 2 completed NCT00811967
Inhibition of Disease Progression in Hepatitis C-infected Patients With Compensated Liver Cirrhosis (P03811) (COMPLETED) treatment 3 terminated NCT01258101
A Study of PEGASYS (Peginterferon Alfa-2a) Plus Ribavirin in Patients With Chronic Hepatitis C (CHC), Genotype 2 or 3 treatment 4 completed NCT00323804
Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy. treatment 2 / 3 completed NCT01371604
Safety and Antiviral Activity of IDX184 in Combination With Pegylated Interferon and Ribavirin for 12 Weeks (MK-2355-005) treatment 2 completed NCT03117569
Trial of Simplified Treatment Monitoring for 8 Weeks Glecaprevir/Pibrentasvir in Chronic Hepatitis C Patients treatment 3 completed NCT05870969
Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese Population (dSEARCH) No drug interventions Not Available Not Available recruiting NCT01447446
An Observational Study on Dual And Triple Therapies Based on Peginterferon Alfa (e.g. Pegasys) in Patients With Chronic Hepatitis C Not Available Not Available completed NCT02557646
An Observational Study to Assess the Effect of Cumulative Ribavirin Dose in Participants With Chronic Hepatitis C Not Available Not Available completed NCT01671046
An Observational Study To Assess Liver Fibrosis Stages in Patients With Chronic Hepatitis C Infection No drug interventions Not Available Not Available completed NCT04202081
Voices From the Black Community: Hepatitis C Research Participation No drug interventions Not Available Not Available completed NCT00686881
Efficacy of Peginterferon Alfa-2b (SCH 054031) vs Glycyrrhizin in Interferon (IFN)-Treated Patients With Chronic Hepatitis C and F2/F3 Liver Fibrosis (P04773) treatment 3 terminated NCT01331850
A Study of Danoprevir/Ritonavir and Copegus With RO5024048 and/or Pegasys in Patients With Chronic Hepatitis C treatment 2 completed NCT02993250
A Study to Investigate the Safety, Pharmacokinetics, and Efficacy of Combination Treatment of AL-335, Odalasvir, and Simeprevir in Japanese Participants With Chronic Hepatitis C Genotype 1 or 2 Virus Infection, With or Without Compensated Cirrhosis Who Are Direct Acting Antiviral Treatment-naive treatment 2 completed NCT00221650
Treatment of Chronic Hepatitis C With PEG Interferon alfa2a and Ribavirin in HIV-Infected Patients treatment 2 completed NCT01945008
Observational Study in HCV Chronic Infection No drug interventions Not Available Not Available completed NCT03594838
Evaluation of HCV Viremia Testing Approaches Among PWID in Georgia No drug interventions diagnostic Not Available completed NCT01366638
A Study of TMC435 in Participants With Genotype 1 Hepatitis C Virus (HCV) Infection treatment 3 completed NCT04177043
Model Towards Elimination of Hepatitis C Infection in Egypt: Feasibility and Effectiveness in 73 Villages No drug interventions screening 4 completed NCT02583243
Project BEST: Buprenorphine Entry Into Substance Abuse Treatment Not Available Not Available completed NCT00867243
Prediction of Hepatitis C Recurrence in Liver Transplant Recipients No drug interventions Not Available Not Available terminated NCT05376943
Possible Differences in HCC Course Depending on DAA Treatment No drug interventions Not Available Not Available unknown_status NCT01482403
A Study of Mericitabine in Combination With Boceprevir and Pegasys/Copegus in Patients With Chronic Hepatitis C treatment 2 completed NCT02465203
3-year Follow-up Study to Assess the Viral Activity in Hepatitis C Patients Who Failed Feeder DEB025/Alisporivir Study other 3 terminated NCT01685203
A Study to Evaluate the Safety and Effect of Co-administration of ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Adults With Chronic Hepatitis C Virus Infection treatment 2 completed NCT01271790
A Study of Response-Guided Duration of Combination Therapy With GS-9451, Pegasys® and Copegus® With and Without Tegobuvir (GS-9190) in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C treatment 2 completed NCT00724464
Efficacy of PegIntron (Peginterferon Alfa-2b) and Rebetol (Ribavirin) in Treatment-naïve Subjects With Chronic Hepatitis C in Clinical Practice in Greece (Study P05209) Not Available Not Available completed NCT02268864
A Study to Assess the Efficacy and Safety of the Combination of Simeprevir and Daclatasvir in Chronic Hepatitis C Genotype 1b-Infected Participants treatment 2 completed NCT00516321
Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Subjects With Hepatitis C Related Liver Disease treatment 3 completed NCT01743521
DAA Based Therapy for Recently Acquired Hepatitis C (DARE-C) treatment 4 completed NCT00292084
An Extension Study to Evaluate the Safety and Efficacy of Celgosivir and Peginterferon Alfa-2b, With or Without Ribavirin, in Patients With Chronic Hepatitis C Genotype 1 Infection treatment 2 completed NCT00441584
The Effects of PegIntron Plus Rebetol in Subjects With Chronic Hepatitis C Not Responding to Pegasys (Study P03833) treatment 3 terminated NCT00237484
Effect of Infliximab on the Efficacy of Peg-Intron/Ribavirin in Patients With Hepatitis C (Study P04257AM4)(COMPLETED) treatment 3 completed NCT02716779
Influence of Ribavirin on the Initial Virological Response in Treatment Naïve Patients With Hepatitis C Genotype 1 Infection treatment 2 completed NCT03063879
Treating Hepatitis C in CRF Using Sofosbuvir and Daclatasvir treatment 4 completed NCT00922779
A Study of Ribavirin in Combination With PEGASYS (Peginterferon Alfa-2a (40KD))in Patients With Chronic Hepatitis C treatment 4 completed NCT03896087
Evaluation of Dried Blood Spot for HCV RNA Testing No drug interventions diagnostic Not Available completed NCT00545233
A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) With or Without Pioglitazone in Treatment-Naive Patients With Chronic Hepatitis C and Insulin Resistance. treatment 4 completed NCT01206933
The Effect of HIV Tat Protein on HCV Replication in an In-vitro Model System No drug interventions Not Available Not Available completed NCT01853254
A Study of Pegasys (Peginterferon Alfa-2a) Administered Alone or in Combination With Copegus (Ribavirin) in Patients With Chronic Hepatitis C Who Have Participated in Previous Pegasys Trials treatment 3 completed NCT00724854
Evaluation of Rapid Virologic Response Among HCV Patients Treated With PegIntron and Rebetol in Brazil (Study P05427) Not Available Not Available completed NCT04061551
Eliminate Hepatitis C/EC Partnership Evaluation Protocol No drug interventions health_services_research Not Available unknown_status NCT00725751
Treatment of Chronic Hepatitis C With Pegylated Interferon and Ribavirin in Participants With/Without Substitution Therapy (P05255) Not Available Not Available completed NCT00561353
A Study of TMC435350 Administered With or Without Standard of Care Therapy in Participants With Genotype 1 Hepatitis C Virus Infection treatment 2 completed NCT00107653
Latino Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) and COPEGUS (Ribavirin) in Treatment-Naive Patients With Chronic Hepatitis C-Genotype 1. treatment 4 completed NCT00686777
Pegylated Interferon (PEG-IFN) Alfa-2b and Low Dose Ribavirin for the Treatment of Chronic Hepatitis C Patients With Genotype 1 High Viral Load and Low Body Weight (Study P05172)(COMPLETED) treatment 4 completed NCT03057847
Sofosbuvir/Velpatasvir in Postpartum Women With Opioid Use Disorder and Chronic Hepatitis C Infection health_services_research 4 completed NCT00723645
Rate and Predictors of Relapse in the Treatment of Hepatitis C (Study P05181) No drug interventions Not Available Not Available completed NCT02461745
Real World Study: Genotype 1 Chronic Hepatitis C Virus Treatment and Evaluation of Real World SVR and PRO treatment 4 completed NCT02806505
HELPS Study - A Study of Peginterferon Alfa-2a (Pegasys) in Patients With Chronic Hepatitis C (CHC) and End-Stage Renal Disease (ESRD) treatment 3 completed NCT00493805
Study of Response in Chronic Hepatitis C (CHC) Participants Genotype 1 With Insulin Resistance and Prolonged Treatment Duration in Late Responders (P04823/MK-4031-303) treatment 4 terminated NCT00725205
Patient Compliance During PegIntron and Rebetol Combination Therapy in Chronic Hepatitis C (Study P04690) Not Available Not Available completed NCT02118597
An Observational Study Examining the Use of Triple Combination Therapy With Boceprevir, Peginterferon Alfa-2a and Ribavirin in the Re-Treatment of Chronic Hepatitis C Patients Not Available Not Available terminated NCT00774397
Antiviral Effect, Safety, and Pharmacokinetics of BI201335 +PegIFN/RBV in HCV-GT1 (SILEN-C1&2) treatment 2 completed NCT01925183
Individualized Triple-therapy Using Boceprevir in HIV-positive Patients With Hepatitis C treatment 4 completed NCT01770483
The Role Of Nitazoxanide, Interferon Alfa And Ribavirin In Treatment Of Hepatitis C Infected Type 2 Diabetic Patients treatment 4 completed NCT00869661
A Study of RO5024048 in Combination With Pegasys and Copegus in Treatment-Naive Patients With Chronic Hepatitis C, Genotype 1 or 4 treatment 2 completed NCT01525628
Drug Drug Interaction Study Between BI 201335 and BI 207127 in Chronic Hepatitis C Infected Patients treatment 1 completed NCT02421211
A Study to Investigate the Pharmacokinetic Interactions Between Simeprevir and Ledipasvir in a Treatment Regimen Consisting of Simeprevir, Sofosbuvir, and Ledipasvir in Treatment-naive Participants With Chronic Hepatitis C Virus Genotype 1 Infection No drug interventions other 2 completed NCT00727311
Real-life Surveillance Study of Patients With Chronic Hepatitis C Treated With PegIntron Injector and Rebetol (Study P04538)(COMPLETED) No drug interventions Not Available Not Available completed NCT02027493
Hansenula-Derived Pegylated-Interferon Alpha-2a in Egyptian Children With Chronic HCV No drug interventions treatment Not Available completed NCT00724893
Efficacy of Pegetron® Redipen™ Treatment and Treatment Compliance of Patients With Chronic Hepatitis C in Canada (P04423) No drug interventions Not Available Not Available completed NCT01066793
PROPHESYS 2: An Observational Study on Predictors of Response in Treatment-naïve Patients With Chronic Hepatitis C Treated With Pegasys (Peginterferon Alfa-2a) or Peginterferon-alfa-2b No drug interventions Not Available Not Available completed NCT00787371
Effect of Low-dose PegIntron on ALT Normalization in Japanese Patients With Chronic Hepatitis C (Study P04508)(COMPLETED) No drug interventions treatment 2 completed NCT01296971
A Study of the Safety of Individualized Combination Therapy With Copegus (Ribavirin) and Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis C (MASTER) No drug interventions treatment 3 withdrawn NCT02014571
Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of Repeat Doses of GSK2878175 in Subjects With Chronic Hepatitis C. No drug interventions treatment 1 completed NCT01371578
Oral Antivirals (GS-5885, Tegobuvir, and/or GS-9451) With Peginterferon Alfa 2a and Ribavirin in Treatment Experienced Subjects With Chronic Genotype 1 Hepatitis C Virus Infection No drug interventions treatment 2 completed NCT04943588
Treating Hepatitis C in Pakistan. Strategies to Avoid Resistance to Antiviral Drugs No drug interventions Not Available Not Available recruiting NCT02556307
A Study of the Effectiveness of Peginterferon Alfa-2a (Pegasys) and Ribavirin Treatment in Slovenian Hepatitis C (HCV) Patients No drug interventions Not Available Not Available completed NCT00087607
Peak Study - A Study of Pegasys (Peginterferon Alfa-2a (40KD)) in Combination With Copegus (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC). No drug interventions treatment 4 completed NCT01590407
First in Human Study of ALS-002200; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C Genotype 1 No drug interventions treatment 1 completed NCT03882307
Levels of Interleukin-6 andTransforming Growth Factor Beta in HCV Patients Sera No drug interventions treatment 0 unknown_status NCT00705107
Adherence to Treatment With PegIntron Pen Plus Rebetol in Treatment-naïve Adult Patients With Hepatitis C in Romania (Study P04247) No drug interventions Not Available Not Available terminated NCT01288209
A Phase III Study of TMC435 in Genotype 1, Hepatitis C-infected Participants Who Failed to Respond to Previous IFN-based Therapy No drug interventions treatment 3 completed NCT02791256
A Study of Peginterferon Alfa-2a Plus Ribavirin in Early Non-Responder Participants With Chronic Hepatitis C (CHC) Genotype 1, 4, 5, and 6 No drug interventions treatment 3 terminated NCT01280656
A Retrospective Study to Assess the Impact of the Use of Interferon in Patients With Chronic Hepatitis C (DECISION) No drug interventions Not Available Not Available completed NCT01168856
An Observational Study on Long-Term Persistence of Resistant Mutations And Durability of Sustained Virological Response in Patients With Chronic Hepatitis C Treated With Direct Acting Antiviral (DAA)- Containing Regimens No drug interventions Not Available Not Available terminated NCT00704756
An Observational Study of Patients With Chronic Hepatitis C Undergoing Treatment With PegIntron and Rebetol in Clinical Practice in Belgium (Study P05494)(WITHDRAWN) No drug interventions Not Available Not Available withdrawn NCT03995485
KW-136 With Sofosbuvir for Chinese Adults With Chronic Hepatitis C No drug interventions treatment 3 completed NCT01554085
First in Human Study of ALS-002158; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C Genotype 1 No drug interventions treatment 1 terminated NCT00963885
A Study of RO5190591 (Danoprevir) in Combination With Pegasys and Copegus in Treatment-Naive Patients With Chronic Hepatitis C Genotype 1 Virus Infection No drug interventions treatment 2 completed NCT02759315
Efficacy and Safety of Uprifosbuvir (MK-3682) With Ruzasvir (MK-8408) in Adults With Chronic Hepatitis C Genotype 1, 2, 3, 4, 5 or 6 Infection (MK-3682-035) No drug interventions treatment 2 terminated NCT01608737
A Phase III Study of BI201335 in Treatment-naive and Prior Relapser Patients With Chronic Hepatitis C Infection No drug interventions treatment 3 withdrawn NCT00148837
Efficacy of Prazosin Versus Placebo Associated With Peg-Interferon Alpha 2b and Ribavirin in Chronic Hepatitis C With Genotype 1 or 4 and Severe Fibrosis No drug interventions treatment 2 unknown_status NCT02011932
Prospective Observational Study of Disease Progression in Chronic Hepatitis C No drug interventions Not Available Not Available active_not_recruiting NCT00723632
Pharmacoeconomic Study Assessing the Cost of Chronic Hepatitis C Treatment With Peginterferon Alfa-2b (PegIntron) and Ribavirin (Rebetol) in the Czech Republic (Study P04588)(COMPLETED) No drug interventions Not Available Not Available completed NCT02206932
A Study of the Safety and Effectiveness of Simeprevir and Sofosbuvir for Patients With HIV and Hepatitis C No drug interventions treatment 4 withdrawn NCT01846832
A Study of TMC435 Plus Pegylated Interferon Alfa-2a and Ribavirin in Participants With Chronic HCV Infection No drug interventions treatment 3 completed NCT02666352
A Study of the Pharmacokinetics of Uprifosbuvir (MK-3682) and Ruzasvir (MK-8408) in Participants With Moderate and Severe Hepatic Insufficiency (MK-3682-029) No drug interventions treatment 1 completed NCT00104052
Study of PEG-Intron Plus REBETOL in Pediatric Subjects With Chronic Hepatitis C (Study P02538 Part 1) No drug interventions treatment 3 completed NCT02226952
Antiviral Efficacy, Pharmacokinetics and Safety of BILN 2061 ZW in Patients With Chronic Hepatitis C Virus Infection No drug interventions treatment 1 / 2 completed NCT02319200
Primary Prevention Hepatocellular Carcinoma by Metformin No drug interventions prevention 3 terminated NCT01606800
Efficacy and Safety of Short Course Therapy With Peginterferon Alpha-2b (PEG-IFN Alfa-2b) and Ribavirin (RBV) for Chronic Hepatitis C (Genotype 4) Participants Achieving a Rapid Virological Response at Week 4 of Treatment (MK-8908B-059) No drug interventions treatment 4 terminated NCT00439959
Monotherapy Versus Placebo Over 14 or 17 Days in Healthy and Hepatitis C Infected Adults No drug interventions diagnostic 1 terminated NCT00216775
Comparative Trial of Standard Versus Low-dose Peg-Interferon Plus Ribavirin in the Treatment of Chronic Hepatitis C No drug interventions Not Available Not Available completed NCT00081770
Peginterferon Dose Evaluations for Previously Untreated Subjects With Chronic Hepatitis C Infected With Genotype 1 (Study P03471) No drug interventions treatment 3 completed NCT00725842
Relapse Rate in Hepatitis C Patients Treated With Peginterferon Alfa-2b Plus Ribavirin in Common Clinical Practice in France (P05484)(Completed) No drug interventions Not Available Not Available terminated NCT00265642
Evaluation of Irbesartan on Hepatic Fibrosis in Chronic Hepatitis C No drug interventions treatment 3 completed NCT01483742
A Study of Ritonavir-Boosted Danoprevir and RO5024048 in Different Combinations in Null Responder or Treatment-Naïve Patients With Chronic Hepatitis C and Compensated Cirrhosis No drug interventions treatment 2 completed NCT02864199
A Study of Peginterferon Alfa-2a (Pegasys) and Ribavirin (Copegus) Combination Therapy in Participants With Chronic Hepatitis C (CHC) and Various Degrees of Renal Impairment No drug interventions treatment 4 completed NCT00378599
Effects of Pegylated Interferon Alfa-2b and Ribavirin After Orthotopic Liver Transplantation in Subjects With Chronic Hepatitis C Recurrence (P04590AM3)(COMPLETED) No drug interventions treatment 3 completed NCT03740906
Direct-acting Antiviral Therapy and Reinfection Among People With Chronic Hepatitis C Virus Infection and Recent Injecting Drug Use in the Prison Setting No drug interventions Not Available Not Available completed NCT03155906
Integrated Treatment of Hepatitis C Virus Infection No drug interventions health_services_research Not Available active_not_recruiting NCT00227149
Long-Term Evaluation Follow-up of Neurocognitive Performance and Emotional State in Patients With Chronic Hepatitis C No drug interventions Not Available Not Available completed NCT01872936
Miravirsen in Combination With Telaprevir and Ribavirin in Null Responder to Pegylated-Interferon Alpha Plus Ribavirin Subjects With Chronic Hepatitis C Virus Infection No drug interventions treatment 2 unknown_status NCT03057236
Pilot Feasibility Study of a Cognitive Behavioral Coping Skills (CBCS) Group Intervention for Hep C Therapy Patients No drug interventions treatment Not Available completed NCT00077636
ACCELERATE Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC) Infection. No drug interventions treatment 4 completed NCT01459913
Efficacy of a 12-Week Regimen of Telaprevir, Pegylated Interferon, and Ribavirin in Treatment-Naive and Prior Relapser Subjects With Interleukin28B (IL28B) CC Genotype No drug interventions treatment 3 terminated NCT00703118
A Safety and Effectiveness Study of Telaprevir in Chronic, Genotype 1, Hepatitis C Patients That Failed Previous Standard Treatment No drug interventions treatment 3 completed NCT00788918
Study of Cerebral Function in Patients With Chronic Hepatitis C Infection (HCV/CNS) No drug interventions Not Available Not Available completed NCT01066819
PROPHESYS 3: Observational Study on Predictors of Response in Patients With Treatment-naïve Chronic Hepatitis C Initiated on Treatment With Pegasys (Peginterferon Alfa-2a) or Peginterferon-alfa-2b No drug interventions Not Available Not Available completed NCT00119119
Efficacy and Safety of Pentoxyphilline and Tocopherol on the Fibrosis in Patients With Chronic Hepatitis C No drug interventions treatment 3 terminated NCT01579019
A Study of RO5024048 in Combination With Ritonavir-Boosted Danoprevir and Pegasys/Copegus in Patients With Chronic Hepatitis C Genotype 1 Who Have Failed Prior HCV Protease Inhibitor Treatment No drug interventions treatment 2 withdrawn NCT03423641
An Observational Study of the Safety of Direct-acting Antivirals in Patients With Hepatitis C No drug interventions Not Available Not Available completed NCT00704717
Evaluation of Patient Satisfaction in Hepatitis C Patients Treated With PegIntron Pen and Rebetol in Romania (Study P04301) No drug interventions Not Available Not Available completed NCT01705717
A Retrospective Study of Real World Treatment Outcomes of Patients With Chronic Hepatitis C No drug interventions Not Available Not Available completed NCT01278134
A Study of RO5024048 in Combination With Ritonavir-Boosted Danoprevir With or Without Copegus (Ribavirin) in Interferon-Naïve Patients With Chronic Hepatitis C Genotype 1 (INFORM-SVR) No drug interventions treatment 2 completed NCT00255034
Effects of 48 Weeks Versus 24 Weeks of Therapy With Peg-Intron/Ribavirin in Patients With Chronic Hepatitis C, Genotype 3 (Study P04143)(TERMINATED) No drug interventions treatment 4 terminated NCT01679834
An Observational Study of Pegasys in Dual- or Triple-Therapy in Patients With Chronic Hepatitis C No drug interventions Not Available Not Available completed NCT00221624
Peginterferon Alfa-2a Plus Ribavirin Plus Amantadine for the Treatment of Hepatitis C Infected Patients No drug interventions treatment 3 completed NCT01585324
A Study of The Relationship Between Drop in Hemoglobin and Sustained Virological Response in Patients With Chronic Hepatitis C Treated With Copegus (Ribavirin) and Pegasys (Peginterferon Alfa-2a) No drug interventions treatment 4 completed NCT00705224
Effect of Insulin Resistance on the Safety and Efficacy of Pegylated Interferon and Ribavirin Treatment in HCV (Study P05562) No drug interventions Not Available Not Available completed NCT00856024
ATHENAS - Retrospective Study of Compliance in Chronic Hepatitis C With Pegylated Interferon Alfa-2b/Ribavirin in Brazil (P05632) No drug interventions Not Available Not Available terminated NCT00122616
Efficacy of Pegylated Interferon on Liver Fibrosis in Co-infected Patient With HIV and Hepatitis C No drug interventions treatment 3 completed NCT00062816
Addition of ISIS 14803 to Therapy With Peginterferon and Ribavirin for Chronic Hepatitis C (HCV) Patients Not Responding Adequately to the Two Drugs No drug interventions treatment 1 / 2 completed NCT03413696
Effects of Health Literacy and HCV Knowledge on HCV Treatment Willingness in HIV-coinfected Patients No drug interventions Not Available Not Available completed NCT00166296
Efficacy and Safety of Escitalopram for Prevention of Depression Induced by Peg-Interferon in Hepatitis C Patients No drug interventions prevention 2 completed NCT01732796
IFN-free Combination Therapy in HCV-infected Patients Treatment-naive:HCVerso1 No drug interventions treatment 3 completed NCT02060058
Boceprevir-based Therapy to Rescue HCV Genotype 1/HBV Infected Patients Refractory to Combination Therapy No drug interventions treatment 3 completed NCT00761735
5 Year Long-term Follow up in Pediatric Participants Who Received PegIntron Plus Rebetol in P02538 Part I (P02538 Pt 2) No drug interventions treatment 3 completed NCT00800735
A Study of PEGASYS (Pegylated-interferon Alfa-2a) With or Without Ribavirin in Patients With Chronic Hepatitis C Who Have Participated in Previous Roche or Roche Partner Protocols No drug interventions treatment 3 completed NCT01528735
This Trial Evaluates Safety, Pharmacokinetic Profile and Anti-viral Response of BI 207127 and BI 201335 for Patients With Chronic Hepatitis C No drug interventions treatment 2 completed NCT03038763
Vertical Transmission of Hepatitis C in Adult Children of Female Baby Boomers No drug interventions Not Available Not Available completed NCT02624063
Randomized Clinical Trial of Sofosbuvir in Combination With Daclatasvir or Simeprevir for 12 Weeks in Non-cirrhotic Subjects Infected With Chronic Hepatitis C Virus Genotype 1 (TNT) No drug interventions treatment 4 completed NCT00705263
Satisfaction in Patients Receiving the PegIntron Pen Plus Rebetol for Hepatitis C (Study P04244)(COMPLETED) No drug interventions Not Available Not Available completed NCT00202839
Peg-Intron/Ribavirin in G 1 HCV for Non-Extended Versus 24 Week Extended Treatment After 24 Weeks (Study P04144)(COMPLETED) No drug interventions treatment 4 completed NCT00863239
Phase 2B Dose Ranging Study of Locteron Plus Ribavirin to Treat HCV No drug interventions treatment 2 completed NCT02226939
Antiviral Efficacy, Pharmacokinetics and Safety of BILN 2061 ZW in Patients With Cirrhosis and Chronic Hepatitis C No drug interventions treatment 2 completed NCT01758939
Predictors of Response to Combined Pegylated Interferon and Ribavirin in Chronic Hepatitis C Infected Egyptian Patients No drug interventions Not Available Not Available unknown_status NCT00217139
A Study to Evaluate the Safety and Efficacy of Celgosivir and Peginterferon Alfa-2b, With or Without Ribavirin, in Patients With Chronic Hepatitis C Genotype 1 Infection No drug interventions treatment 2 completed NCT00704522
Adherence in Patients Receiving PegIntron Pen/Rebetol for Hepatitis C in Conjunction With a Patient Assistance Program (Study P04281)(COMPLETED) No drug interventions Not Available Not Available completed NCT02176525
Multiple Oral Doses of BI 207127 NA in Treatment naïve and Treatment-experienced Hepatitis C Virus (HCV)-Infected Patients No drug interventions treatment 1 completed NCT01919125
Pharmacokinetics of IDX719 in Participants With Normal and Impaired Hepatic Function (MK-1894-008) No drug interventions treatment 1 completed NCT01200225
An Observational Study on The Impact of Insulin Resistance on Sustained Virological Response in Patients With Hepatitis C Treated With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) No drug interventions Not Available Not Available completed NCT00030030
Evaluating Silymarin for Chronic Hepatitis C No drug interventions prevention 2 completed NCT00553930
Low Dose Peginterferon-α 2a for Chronic Hepatitis C, Genotypes 2 or 3, in HIV-coinfected Patients No drug interventions treatment 4 completed NCT01508130
An Observational Study of Peginterferon (e.g. Pegasys)-Based Direct Acting Antiviral Triple Therapy in Patients With Chronic Hepatitis C Genotype 1 No drug interventions Not Available Not Available completed NCT00724230
Safety and Efficacy of PegIntron Plus Rebetol in Patients With Chronic Hepatitis C in Japan, Excluding (1) Subjects With HCV Genotype 1 and High Viral Load, and (2) Interferon-naïve Subjects With Low Viral Load (Study P04841)(COMPLETED) No drug interventions Not Available Not Available completed NCT01760148
Patterns of Early Hepatitis C Virus Decline Predict the Outcome of Interferon Therapy (sIFN-pred2) No drug interventions Not Available Not Available unknown_status NCT04302948
Rapid HCV RNA Testing and LInkage to Care No drug interventions treatment Not Available terminated NCT01033448
A Study of Extended Therapy of PEGASYS (Peginterferon Alfa-2a) in Combination With COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C and Slow Response No drug interventions treatment 4 completed NCT00726557
Post-marketing Surveillance Study of Ex-intravenous Drug Abusers With Chronic Hepatitis C Treated With PegIntron Plus Rebetol (P04408/MK-4031-261) No drug interventions Not Available Not Available completed NCT04460157
Prediction of Liver-related Outcomes After HCV Cure No drug interventions Not Available Not Available unknown_status NCT03219957
Study of AT-527 in Healthy and HCV-Infected Subjects No drug interventions treatment 1 completed NCT01435226
GS-5885, GS-9451, Tegobuvir and Ribovirin in Treatment-Experienced Subjects With Chronic Genotype 1a Or 1b Hepatitis C Virus (HCV) Infection No drug interventions treatment 2 completed NCT02597166
Effects of Harvoni in Patients With Decompensated Cirrhosis Due to Hepatitis C Genotype 1 Infection No drug interventions treatment 3 completed NCT00279565
Buprenorphine Versus Methadone Maintenance in Hepatitis C Patients Receiving Peg-Intron and Rebetol (Study P04279)(TERMINATED) No drug interventions treatment 4 terminated NCT00940420
A Study of Combination Treatment With Pegasys (Peginterferon Alfa) and Copegus (Ribavirin)in Patients With Chronic Hepatitis C No drug interventions treatment 4 completed NCT01447420
A Study of Sustained Virological Response in Relation to IL28-b Expression in Treatment-Naïve Patients With Chronic Hepatitis C Genotype 1 on Combination Treatment With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) No drug interventions treatment 4 completed NCT01544920
Safety and Efficacy of Boceprevir/Peginterferon Alfa-2a/Ribavirin in Interleukin-28B CC Allele-Positive Chronic Hepatitis C Virus (HCV) Genotype 1 Participants (P07755) No drug interventions treatment 3 completed NCT02113631
Comparative Effectiveness and Tolerability of Boceprevir vs Telaprevir No drug interventions treatment Not Available completed NCT00723931
PegIntron Injection Surveillance Plan (Study P04123) No drug interventions Not Available Not Available completed NCT01290731
A Study of TMC435 in Genotype 1, Hepatitis C-infected Patients Who Relapsed After Previous Interferon (IFN)-Based Therapy No drug interventions treatment 3 completed NCT01054573
VX-950-TiDP24-C219: A Roll Over Trial for Patients in the Control Group of the C216 Study Who Received Telaprevir Placebo No drug interventions treatment 3 completed NCT01830127
BI 207127 / Faldaprevir Combination Therapy in Hepatic Impairment (Child-Pugh B) Patients With Genotype 1b Chronic Hepatitis C Infection: HCVerso3 No drug interventions treatment 2 completed NCT03170076
Pattern of Skin Manifestations in Chronic Hepatitis c Virus Patients Before and After Direct Acting Anti Viral Drugs No drug interventions Not Available Not Available unknown_status NCT01798576
An Observational Study of Pegasys (Peginterferon Alfa-2a) Plus Ribavirin Based Regimens in Patients With Chronic Hepatitis C With Previous Treatment Failure No drug interventions Not Available Not Available terminated NCT00728494
Compliance of HCV Genotype 1 Infected Patients Receiving PegIntron/Rebetol and a Patient Assistance Program (Study P04671) No drug interventions Not Available Not Available completed NCT05813691
Epidemiology of Occult Hepatitis C Virus Infection in Patients Born Before 1969 in the Hospital Setting: a Spontaneous Opportunistic Screening Initiative. No drug interventions Not Available Not Available not_yet_recruiting NCT02707991
Nurse Case Management to Improve Hepatitis C Care in HIV Co-infection No drug interventions health_services_research Not Available completed NCT03416491
Safety and Efficacy of KW-136 and Sofosbuvir for Treatment of Chronic Hepatitis C No drug interventions treatment 2 completed NCT00039962
Thymosin Plus PEG-Interferon in Hepatitis C Patients With Cirrhosis Who Did Not Respond to Interferon or Interferon Plus Ribavirin No drug interventions treatment 3 completed NCT01849562
Safety, Tolerability, and Efficacy of 12-weeks of Sovaprevir, ACH-3102, and Ribavirin in Treatment-naive GT-1 HCV Participants No drug interventions treatment 2 completed NCT02761629
Efficacy and Safety of Peg-Interferon Alpha-2a Plus Ribavirin in Genotype 1 Chronic Hepatitis C Participants Co-Infected With Human Immunodeficiency Virus No drug interventions treatment 4 completed NCT02850289
APPROACH Study: Quality of Life and Outcomes Assessment in Participants With Chronic Hepatitis C (CHC) Treated With Pegylated Interferon (PEG-IFN) Alfa-2a and Ribavirin No drug interventions Not Available Not Available completed NCT00723892
Adherence in Patients Receiving PegIntron/Rebetol for Hepatitis C in Conjunction With a Psychotherapy Support Program (Study P04252) No drug interventions Not Available Not Available completed NCT01570244
Drug-drug Interaction of BI 201335 and Microgynon No drug interventions treatment 1 completed NCT01390844
Safety and Efficacy of Boceprevir in Asia Pacific Participants With Chronic Hepatitis C Genotype 1 (P07063) No drug interventions treatment 3 completed NCT01087944
A Study of Administration of Peginterferon Alfa-2a [Pegasys] by Autoinjector Versus Pre-filled Syringe in Patients With Chronic Hepatitis C No drug interventions treatment 1 completed NCT01435044
Safety Study of Regimens of Sofosbuvir, GS-0938, and Ribavirin in Patients With Chronic Hepatitis C Infection No drug interventions treatment 2 completed NCT00088140
A Caspase Inhibitor in Chronic Hepatitis C (HCV) Patients No drug interventions treatment 2 completed NCT05397067
Linkage to Care for Persons With Hep C Infection No drug interventions supportive_care Not Available recruiting NCT00782301
Maraviroc Versus Etravirine In Combination With Antiretroviral Therapy In Drug Experienced HIV And Hepatitis Co-Infected Patients No drug interventions treatment 4 withdrawn NCT00700401
POTENTE Study: A Study of Early Virological Response in Naive Patients With Chronic Hepatitis C, Genotype 2 or 3, Treated With PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Copegus (Ribavirin). No drug interventions Not Available Not Available completed NCT04382404
Treatment of Chronic Hepatitis C During Pregnancy With Sofosbuvir/Velpatasvir No drug interventions treatment 1 completed NCT00475072
A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Ribavirin in Hemophiliac Patients With Chronic Hepatitis C. No drug interventions treatment 4 completed NCT00718172
Viral Kinetics and Liver Gene Expression in Response to Ribavirin and Peginterferon Therapy of Chronic Hepatitis C No drug interventions treatment 1 completed NCT00087568
A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Ribavirin in Patients With Chronic Hepatitis C (CHC) Previously Treated With PEG-Intron + Ribavirin No drug interventions treatment 4 completed NCT02969668
Interferon-free Antiviral Treatment of Chronic Hepatitis C Virus Infection Among Opioid-substituted Patients No drug interventions Not Available Not Available completed NCT03459768
Cohort Study on People Who Inject Drugs in Senegal No drug interventions Not Available Not Available unknown_status NCT00529568
Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Benefit Subjects With Hepatitis C Liver Disease No drug interventions treatment 3 completed NCT01457768
A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response No drug interventions Not Available Not Available completed NCT00154869
Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/Hepatitis B Co-Infection and Chronic Hepatitis C No drug interventions treatment 3 unknown_status NCT04428346
A Trial to Assess the Effect of an Intervention Integrating Contingency Management (Financial Incentives) to Enhance Hepatitis C Treatment Uptake Following Dried Blood Spot Hepatitis C RNA Testing Among People With Recent Injecting Drug Use Attending Needle and Syringe Programs No drug interventions other Not Available unknown_status NCT03453346
Safety and Efficacy of Generic Sofosbuvir and Ribavirin for Treatment-naive Genotype 2 Chronic Hepatitis C No drug interventions treatment Not Available completed NCT00087646
REPEAT Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Therapy in Combination With COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Who Did Not Respond to Previous PegIntron (Peginterferon Alfa-2b (12KD))/Ribavirin Combination Therapy No drug interventions treatment 4 completed NCT04029246
Re-engaging Patients With Hepatitis C Into Care No drug interventions health_services_research Not Available unknown_status NCT02469012
Neurocognitive Performance and Emotional State in HCV Patients With IFN-free Antiviral Therapy No drug interventions screening Not Available unknown_status NCT03549312
Switch to Genvoya Followed by HCV Therapy With Epclusa Followed by Simplification of HIV Therapy With Biktarvy in Patients With HIV-HCV Co-Infected Subjects on Opioid Substitution Therapy No drug interventions treatment 4 unknown_status NCT01416610
An Observational Study of Pegasys (Peginterferon Alfa-2a) Plus Copegus (Ribavirin) in Participants With Chronic Hepatitis C (CHC), Genotype 2, 3, 1 or 4, Undergoing Opioid Maintenance Therapy No drug interventions Not Available Not Available completed NCT05474781
Eliminating HCV Infection Among PWUD No drug interventions Not Available Not Available recruiting NCT00302081
Three Regimens of PegIntron Plus Ribavirin in Previously Untreated Chronic Hepatitis C, Genotype 2 or 3 (Study P03548) No drug interventions treatment 3 completed NCT00265395
Extended Treatment With PEG-Intron® and Rebetol® in Patients With Genotype 1 Chronic Hepatitis C and Slow Virologic Response (Study P03685) No drug interventions treatment 3 completed NCT01440595
Grazoprevir (MK-5172) With Peg-Interferon and Ribavirin in Participants With Chronic Genotype 2 or 3 Hepatitis C (MK-5172-012) No drug interventions treatment 2 terminated NCT00724295
Safety and Efficacy of PegIntron and Rebetol Combination Therapy in Patients With Chronic Hepatitis C in Japan (Study P04505) No drug interventions Not Available Not Available completed NCT01457755
Gilead Sustained Virologic Response (SVR) Registry No drug interventions Not Available Not Available completed NCT00474955
A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Chronic Hepatitis C and Chronic Renal Failure. No drug interventions treatment 4 completed NCT01332955
Telaprevir in HIV-HCV Coinfected Patients Who Had Previously Failed a Peginterferon-Ribavirin Regimen No drug interventions treatment 2 completed NCT00801255
A Study of Combination Treatment With an HCV Polymerase Inhibitor (RO5024048) and an HCV Protease Inhibitor (RO5190591/Danoprevir) in Genotype 1 Chronic Hepatitis C Patients No drug interventions treatment 1 completed NCT01070550
PROPHESYS 1: An Observational Study on Predictors of Response in Treatment-naïve Patients With Chronic Hepatitis C Virus (HCV)Treated With Pegasys (Peginterferon Alfa-2a) No drug interventions Not Available Not Available completed NCT01749150
A Study of Ritonavir-Boosted Danoprevir in Combination With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) in Patients of Asian Origin With Chronic Hepatitis C Genotype 1 With or Without Cirrhosis No drug interventions treatment 2 completed NCT03000023
Anticipated and Perceived Benefits Following Hepatitis C Treatment No drug interventions Not Available Not Available completed NCT00299923
Study for Patients With Chronic HCV (GT 1 or 3) Who Relapsed to Previous (Peg)Interferon/ Ribavirin Combination Therapy No drug interventions treatment 3 unknown_status NCT05091008
Treatment of Chronic Hepatitis C Infection by Ledipasvir/Sofosbuvir in Naïve Children No drug interventions treatment 2 completed NCT05062408
Impact of the Sustained Viral Response of Chronic Hepatitis c After Treatment With Direct Action Antivirals No drug interventions Not Available Not Available completed NCT00115908
A Study of Albuferon and Ribavirin in Interferon Naive Subjects With Chronic Hepatitis C Genotype 1 No drug interventions treatment 2 completed NCT00255008
Peg-Intron and Rebetol Therapy in Treatment of Naive Hepatitis C Patients: A Comparison of Race and Genotype on Treatment Outcome (Study P04212) No drug interventions treatment 4 terminated NCT00483938
The Individualized Management With Pegylated-interferon Alfa-2a (Pegasys) and Ribavirin (Copegus) Offering Viral Eradication: A Study of Pegylated-interferon Alfa-2a Plus Ribavirin in Participants With Chronic Hepatitis C (CHC) Non-genotype 2/3 (IMPROVE) No drug interventions treatment 3 completed NCT03003338
MHH-HCV-NPM-Neuropsychiatric Manifestations of HCV-infection During and After Treatment With OBV/PTV/r and DSV No drug interventions treatment 4 terminated NCT02161952
Pirfenidone, an Antifibrotic and Antiinflammatory Drug treatment 2 completed NCT06373198
Implementation of a Re-engagement Program for Hepatitis C Patients Lost to Follow-up in Argentina. No drug interventions Not Available Not Available not_yet_recruiting NCT01544582
Drug Utilization of Boceprevir and Clinical Management of Health Outcomes of Interest in Chronic Hepatitis C Participants (P08518) No drug interventions Not Available Not Available completed NCT00807001
Double-Blind, Dose-Escalation Study of IDX184 in Chronic Hepatitis C Treatment-Naïve Subjects No drug interventions treatment 1 / 2 completed NCT01997203
Long Term Vitamin D Therapy in HCV Treated Patients No drug interventions treatment 3 terminated NCT02508090
Long-Term Extension Study of Miravirsen Among Participants With Genotype 1 Chronic Hepatitis C (CHC) Who Have Not Responded to Pegylated-Interferon Alpha Plus Ribavirin No drug interventions Not Available Not Available completed NCT06180590
The Efficacy of Vosevi in Treating DAA-experienced Patients No drug interventions Not Available Not Available recruiting NCT05170490
Long Term Follow up of Chronic HCV Patients Receiving DAAS No drug interventions Not Available Not Available unknown_status NCT00927290
Pioglitazone vs. Placebo in Association With Pegylated Interferon and Ribavirin in HCV Patients With Insulin Resistance No drug interventions treatment 3 terminated NCT00006164
Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard Treatment No drug interventions prevention 3 completed NCT04997564
The Efficacy and Safety of 12-week SOF/VEL Regimen Combined With Prophylactic Use of TAF for Treatment-naïve Genotype 1-6 HCV/HBV Co-infection Adult Patients With or Without Compensated Cirrhosis in China No drug interventions treatment 4 unknown_status NCT03941821
Glecaprevir/Pibrentasvir Real-world Study in China No drug interventions Not Available Not Available unknown_status NCT03098121
Efficacy and Tolerability of Grazoprevir and Elbasvir in Patients With Chronic Genotype 1 HCV and HIV Co-infection No drug interventions treatment 4 completed NCT00395421
Study to Evaluate Drug-drug Interaction Between Valopicitabine and Ribavirin No drug interventions treatment 2 completed NCT02442284
A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin in US Veterans With Genotype 1 Chronic Hepatitis C Virus Infection No drug interventions treatment 3 completed NCT00602784
Phase II Study of Immunization With a Hepatitis C Virus (HCV) Antigen Peptide Vaccine No drug interventions treatment 2 completed NCT01468584
Efficacy and Safety of MP-424, Peginterferon Alfa-2b and Ribavirin in Non-responder Genotype 2 Hepatitis C Infected Patients No drug interventions treatment 3 completed NCT04198584
Study of Telemedicine Stress Management and Lifestyle Group Intervention for HCV Patients No drug interventions treatment Not Available completed NCT00336479
Phase 2 Study of VX-950, Pegasys®, and Copegus® in Hepatitis C No drug interventions treatment 2 completed NCT00322179
Microarray Analysis of IFN-Induced Gene Expression in Obese and Non-Obese Patients With Chronic Hepatitis C No drug interventions Not Available Not Available completed NCT00960479
Relative Bioavailability Study of Ribavirin 200 Capsules and Rebetol 200 mg Capsules in Females Under Fasting Conditions No drug interventions treatment 1 completed NCT00262379
Use or Non-use of Epoetin Beta in Patients Infected by Chronic Hepatitis C No drug interventions treatment 3 completed NCT00084279
CIFN and IFN γ-1b With or Without Ribavirin for Treatment of Chronic Hepatitis C (Nonresponders) No drug interventions treatment 2 completed NCT01360879
Assessment of Liver FIBROsis by Real-time Tissue ELASTography in Chronic Liver Disease No drug interventions Not Available Not Available unknown_status NCT01684787
Study to Evaluate the Treatment for Chronic Hepatitis C With Normal Transaminases in HIV Positive Patients treatment 4 completed NCT03483987
Re-treatment of HCV Following DAA Failure No drug interventions treatment Not Available terminated NCT01974687
Single and Multiple Dose Study of Uprifosbuvir (MK-3682/IDX21437) in Healthy and Hepatitis C Virus (HCV)-Infected Participants (MK-3682-001) treatment 1 / 2 completed NCT00959933
Relative Bioavailability Study of Ribavirin 200 Capsules and Rebetol 200 mg Capsules in Females Under Non-Fasting Conditions treatment 1 completed NCT02638233
Therapy With Ledipasvir/Sofosbuvir in Patients With Genotype 1 HCV Infection Receiving Opiate Substitution Therapy treatment 4 unknown_status NCT01609933
A Study to Evaluate the Safety and Effect of Treatment With Experimental Antiviral Drugs in Combination With Peginterferon Alpha-2a and Ribavirin in People With Hepatitis C Virus Who Did Not Respond to Treatment in a Previous AbbVie/Abbott Combination Study treatment 2 completed NCT00001854
Long-Term Therapy With Ribavirin for Chronic Hepatitis C treatment 4 completed NCT00641654
Combination Therapy With Pegylated Interferon and Ribavirin in Patients With Chronic Hepatitis C Genotype 2 or 3 Infection Who Previously Have Relapsed After Therapy With Pegylated Interferon and Ribavirin treatment 4 terminated NCT00418054
Study of Nitazoxanide Combined With Peginterferon Compared to Peginterferon Monotherapy in the Treatment of Hepatitis C treatment 2 completed NCT01842451
A Phase 2 Study to Evaluate the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of VX-135 and Daclatasvir in Subjects With Genotype 1 Chronic Hepatitis C Chronic Hepatitis C treatment 2 completed NCT00304551
A Study of Peginterferon Alfa-2a in Combination With Ribavirin in Chronic Hepatitis C (CHC) Patients With Compensated Liver Cirrhosis (LC) treatment 3 completed NCT04071353
Observational Cohort Study of Clinical Outcomes After Antiviral Therapy for Chronic Hepatitis C Not Available Not Available unknown_status NCT00782353
Safety, Tolerability, and Antiviral Activity of ANA598 in Patients With Genotype-1 Chronic HCV Infection No drug interventions treatment 1 completed NCT02101177
Evaluation of the National Treatment Program of Hepatitis C in Egypt No drug interventions Not Available Not Available withdrawn NCT02219477
A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis treatment 3 completed NCT00559247
A Single Ascending Dose Study of BMS-650032 in HCV Infected Subjects No drug interventions treatment 1 / 2 completed NCT01639547
Sustained Virological Response (SVR)Rate of Pegasys Plus Ribavirin in Patients With Chronic Hepatitis C supportive_care Not Available terminated NCT01911845
An Open-label, Single Arm, Phase 2 Study to Evaluate ABT-450/r/ABT-267 and ABT-333 With Ribavirin (RBV) in Adults With Genotype 1 HCV Infection Taking Methadone or Buprenorphine treatment 2 completed NCT00540345
Four Arms, Multicenter Study of Tailored Regimens With Peginterferon Plus Ribavirin for Genotype 2 Chronic Hepatitis C treatment 4 completed NCT02216045
Effect of Camel Milk on Chronic Hepatitis C treatment 2 completed NCT02615145
Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Germany (LIFE-C) No drug interventions Not Available Not Available completed NCT01492998
Role of FXR in Hepatitis C Virus Replication No drug interventions treatment Not Available terminated NCT01581398
Efficacy and Safety Study of Peginterferon Alfa-2b in Chinese Chronic Hepatitis C Patients treatment 3 completed NCT04039698
Monitoring of Hepatitis C Treatment Using Telemedicine - a Clinical Trial in Public Health System in Brazil health_services_research Not Available unknown_status NCT01310205
Extension Study SCI-SCV-HCV-P2-001: Long-Term FU in Subj Who Opt for Retreatment With Peg-INF and RBV After Completing Treatment in HCV Not Available Not Available completed NCT04136405
Cross Sectional Survey on the Burden, Impacts and Causes of Hepatitis C Virus (HCV) Outbreak in South West Region in Burkina Faso No drug interventions Not Available Not Available unknown_status NCT03490097
Statins in Chronic Hepatitis C Patients Receiving Sofosbuvir/Daclatasvir Combination treatment 2 / 3 completed NCT01140997
Efficacy and Safety of Ypeginterferon Alfa-2b in Chronic Hepatitis C treatment 2 completed NCT01939197
A Multipart, Open-label Study to Evaluate the Safety and Efficacy of ABT-450/r/ABT-267 With and Without ABT-333 Coadministered With and Without Ribavirin in Adult With Genotype 1 or 4 Hepatitis C Virus (HCV) Infection and Human Immunodeficiency Virus, Type 1 Coinfection treatment 2 / 3 completed NCT01402583
Menopause is a Critical Factor in Determining Failure of Antiviral Therapy in Women With Chronic Hepatitis C Not Available Not Available completed NCT01384383
GS-5885, GS-9451 With Peginterferon Alfa 2a (PEG) and Ribavirin in Treatment-Naïve Subjects With Chronic Genotype 1 Hep C Virus Infection and IL28B CC Genotype treatment 2 terminated NCT02168361
The SIM-SOF Trial for Hepatitis C treatment 4 completed NCT02618928
The Effectiveness of Paritaprevir/Ritonavir - Ombitasvir, ± Dasabuvir, ± Ribavirin in France No drug interventions Not Available Not Available completed NCT00402428
Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared With Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients treatment 3 completed NCT02716428
A Study of Faldaprevir, TD-6450 and Other Antivirals in Participants With Genotype 1b Hepatitis C Virus Infection treatment 2 completed NCT01335711
CHRONVAC-C Study Followed by Standard of Care in Chronic Hepatitis C Virus (HCV) Subjects No drug interventions treatment 2 unknown_status NCT00882193
Pilot Study of Betaine + Combination Antiviral Therapy for Chronic Hepatitis C Genotype 1 Non-responder/Relapsers treatment 0 terminated NCT02609893
Pilot Treatment as Prevention for HCV Among Persons Who Actively Inject Drugs No drug interventions treatment 4 completed NCT00466271
Prediction of Significant Hepatic Fibrosis in HCV Carriers With PNALT by SAPI- A Validation Study No drug interventions Not Available Not Available completed NCT00286871
Randomized Controlled Trial in Liver Transplant Recipients Treated in Steroid Sparing Regimen treatment 1 completed NCT02582671
The Effectiveness of ABT-450/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C -An Observational Study in Ireland Not Available Not Available completed NCT01903278
Efficacy and Safety Study of PEG-IFN-SA and Ribavirin to Treat Chronic Hepatitis C treatment 3 completed NCT01542788
Sofosbuvir + Ribavirin for 12 Weeks in Subjects With Chronic Genotype 2 or 3 Hepatitis C Infection Who Are Interferon Intolerant, Interferon Ineligible or Unwilling to Take Interferon treatment 3 completed NCT02250807
Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Subjects With Chronic Genotype 4 Hepatitis C Virus Infection treatment 3 completed NCT00800007
Study of Safety and Tolerability of Multiple Intravenous Doses of ANZ-521 in Adults With Chronic Hepatitis C Virus No drug interventions treatment 1 / 2 terminated NCT00830609
High Dose Versus Standard Dose of Ribavirin in Patients With Chronic Hepatitis C, Genotype 3 treatment 4 completed NCT01951209
Pilot Study Of The Effect Of Rifaximin On B-Cell Dysregulation In Cirrhosis basic_science Not Available terminated NCT01377909
HCV Treatment With Fluvastatin, Simvastatin to Improve Interferon Sensitivity No drug interventions diagnostic 1 terminated NCT02282709
Effect of ASV and DCV Therapy on the Quality of Immune Status in Chronic HCV Patients basic_science 3 completed NCT02758509
Impact of Antiviral Therapy on Gastroesophageal Varices. Not Available Not Available completed NCT02106156
Observational Study Evaluating the Quality of Pegylated Interferon Alfa-2a and Ribavirin Treatment for Chronic Hepatitis C in Cooperation With the BNG (Association of German Resident Gastroenterologists) Not Available Not Available completed NCT00411385
Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared to Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients Geno2/3 treatment 3 completed NCT01817985
A Phase 1 Study to Evaluate the Pharmacokinetics of GS-5816 in Subjects With Normal Hepatic Function and Moderate or Severe Hepatic Impairment treatment 1 completed NCT00372385
Phase 2 Study of VX-950, Pegasys® With and Without Copegus® in Hepatitis C treatment 2 completed NCT00546715
A Single Ascending Dose Study of Daclatasvir (BMS-790052) in Hepatitis C Virus Infected Subjects treatment 1 / 2 completed NCT02798315
Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study No drug interventions Not Available Not Available completed NCT02617615
A Trial to Evaluate Safety, Tolerability, PK and Antiviral Activity of MB-110 in Hepatitis C Virus Infected Patients No drug interventions treatment 1 unknown_status NCT01831037
The Regression of Liver Fibrosis and Risk for Hepatocellular Carcinoma (ROLFH) Study No drug interventions Not Available Not Available withdrawn NCT00225537
4-Methylumbelliferone as a Treatment for Chronic HBV/HCV treatment 2 unknown_status NCT02642432
A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis treatment 3 completed NCT01511432
A Study to Assess the Relative Bioavailability Three New Formulations of Telaprevir in Healthy Subjects Not Available 1 completed NCT03710252
A Study to Investigate HCV Response Rates in Real World Patients: HEARTLAND Study treatment 4 completed NCT01790100
A Phase 2a, Dose-Ranging Study to Evaluate the Safety, Pharmacokinetics and Efficacy of VX-135 With Ribavirin in Treatment-Naïve Subjects With Chronic Hepatitis C treatment 2 completed NCT03348059
Anti-E1E2 (D32.10 Epitope-binding) Antibodies Status Prior Therapy Favors Direct-acting Antiviral Treatment Efficacy No drug interventions Not Available Not Available completed NCT00423670
Safety and Efficacy of SCH 503034 in Previously Untreated Subjects With Chronic Hepatitis C Infected With Genotype 1 (Study P03523) treatment 2 completed NCT03495570
Sysmex-XN 20 Analyser to Assess Lymphocyte Subsets and Other Haematological Parameters in Chronic/Acute Viral Infections No drug interventions Not Available Not Available unknown_status NCT00601770
Virological Response Study of the HCV Vaccine IC41 No drug interventions treatment 2 completed NCT02112942
Study Assessing Single and Multiple Doses of IDX21459 in Healthy and HCV-Infected Subjects No drug interventions treatment 1 terminated NCT00546442
Treatment Insulin Resistence in HCV G-1 Patient treatment 4 completed NCT00485342
RIBAJUSTE Clinical Trial Investigating the Efficacy and Safety of Dose Adaptation of Ribavirin treatment 3 unknown_status NCT00680342
Phase II Trial of Silymarin for Patients With Chronic Hepatitis C Who Have Failed Conventional Antiviral Treatment treatment 2 completed NCT00736242
Post-marketing Surveillance of HIV-infected Patients With Chronic Hepatitis C Treated With PegIntron Pen and Rebetol (Study P04584) Not Available Not Available completed NCT04614142
Single Patient Protocol for Donor HCV-positive to Recipient HCV-negative Kidney Transplant in a Patient at Risk for Loss of Dialysis Access prevention 4 withdrawn NCT03022006
Safety and Effect of Elbasvir/Grazoprevir Combination Therapy in Hemodialysis Patients With Chronic Hepatitis C treatment 4 unknown_status NCT00656006
A Study of Albuferon With Ribavirin in Interferon Alfa Naive Subjects With Chronic Hepatitis C Genotype 2 or 3 treatment 2 completed NCT03163849
Assessment Effects After Direct Acting Antiviral in Chronic Hepatitis c Virus Patients treatment 3 unknown_status NCT01623336
BIP48 (Peginterferon Alfa 2b 48kDa) Compared With Pegasys® (Peginterferon 2a 40kDa) for Treatment of Chronic Hepatitis C treatment 2 / 3 unknown_status NCT00299936
Comparison of PEG-Intron and Two Different Doses of Ribavirin for the Treatment of Chronic Hepatitis C In Treatment Naïve Subjects treatment 3 completed NCT01144936
Study of VX-985 in Subjects With Chronic Hepatitis C No drug interventions treatment 1 completed NCT01274013
Vitamin D Deficiency in Subjects With Chronic Hepatitis C Compared to Healthy Volunteers No drug interventions Not Available Not Available withdrawn NCT03155113
Role of the Host Immunity in the Non-response to Direct Anti-viral Agent (DAA) Therapy No drug interventions other Not Available completed NCT01459419
Oral Administration of Anti-CD3 Monoclonal Antibody in Non-responder Genotype-I Chronic Hepatitis C Subjects treatment 2 unknown_status NCT00199719
Study of the Pharmacokinetic Action of Amantadine and Ribavirin in Chronic Hepatitis C. CINAM treatment 2 completed NCT01634919
Histologic Changes and Noninvasive Assessment in Hepatitis C Patients Treated With Peginterferon Alpha-2a and Ribavirin No drug interventions Not Available Not Available completed NCT01513941
An Efficacy and Safety Study of Telaprevir in Patients Infected With Both Chronic Hepatitis C Virus (HCV-1) and Human Immunodeficiency Virus (HIV-1) treatment 3 completed NCT03346941
Side Effects After Direct-acting Antiviral Treatment No drug interventions Not Available Not Available completed NCT02604017
A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Subjects With Genotype 1 Infection treatment 3 completed NCT02446717
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ABT-493 and ABT-530 With and Without Ribavirin in Adults With HCV Who Failed a Prior DAA Containing Therapy treatment 2 / 3 completed NCT02476617
Ombitasvir/ABT-450 (Paritaprevir)/Ritonavir With Dasabuvir and Ribavirin (RBV) in Treatment Naive and Treatment Experienced Genotype 1a Hepatitis C Virus Infected Adults treatment 3 completed NCT00370617
Pegylated-Interferon and Ribavirin Plus Metformin in the Treatment of Chronic HCV Infection and Insulin Resistance treatment 4 unknown_status NCT00048724
Peg-Intron for Prevention of Disease Progress in Chronic Hepatitis C Patients With Cirrhosis (Study P02569) treatment 3 completed NCT00926016
Pioglitazone on Viral Kinetics, Cytokines and Innate Immunity in Insulin Resistant CHC GT 1 Subjects Not Available Not Available completed NCT02511496
Status of Chronic Liver Disease in Hepatitis C Virus (HCV) Patients Coinfected With Human Immunodeficiency Virus (HIV) in Andalusia No drug interventions Not Available Not Available unknown_status NCT01289496
Ribavirin Dose Optimization for the Treatment of Hepatitis C treatment 2 completed NCT03673696
The Tolerability and Pharmacokinetics Study of HEC74647PA Capsule in Healthy Adult Subjects No drug interventions treatment 1 completed NCT02582658
Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Austria (REAL) No drug interventions Not Available Not Available completed NCT00722358
A Multiple Ascending Dose Study of BMS-650032 in HCV Infected Subjects treatment 2 completed NCT02745535
Safety, Tolerability and Efficacy of Sofosbuvir, Velpatasvir, and Voxilaprevir in Subjects With Previous DAA Experience treatment 2 completed NCT01908335
A Phase Ⅱ Dose-escalating Study of PEG-IFN-SA and Ribavirin in IFN Naive Patients With Chronic Hepatitis C treatment 2 completed NCT04208035
Hepatitis C Elimination in the Netherlands No drug interventions Not Available Not Available unknown_status NCT02785835
Hepatocellular Carcinoma in HIV-infected Patients No drug interventions Not Available Not Available completed NCT02545335
Neutrophil Function During Therapy With Protease Inhibitors in Chronic Hepatitis C No drug interventions Not Available Not Available completed NCT00189163
Pioglitazone in Hepatitis C treatment 4 completed NCT00196586
Efficacy and Safety of Addition of IL-2 to Pegylated Interferon Alpha 2a and Ribavirin in HIV/HCV Coinfected Patients treatment 2 completed NCT01724086
A Study to Evaluate the Safety, Tolerability, and Effectiveness of a 12-Week Combination Therapy of TMC647055 and TMC435 With and Without GSK23336805 With a Pharmacokinetic Enhancer With and Without Ribavirin in Patients Infected With Chronic Genotype 1 Hepatitis C Virus treatment 2 completed NCT02161939
A Multicenter Treatment Protocol of Daclatasvir (BMS-790052) in Combination With Sofosbuvir for the Treatment of Post-Liver Transplant Subjects With Chronic Hepatitis C Not Available Not Available no_longer_available NCT02068222
A Study to Evaluate the Safety and Antiviral Effect of ABT-450/Ritonavir and ABT-530 Coadministered With and Without Ribavirin in Adults With Genotype 3 Hepatitis C (HCV) Infection treatment 2 completed NCT01590225
Efficacy and Safety of Boceprevir in Combination With Peginterferon Alfa-2b Plus Ribavirin in Pediatric Subjects With Chronic Hepatitis C Genotype 1 (P08034) treatment 3 withdrawn NCT00624325
Subcutaneous Continuous Infusion of Interferon Alfa-2b and Ribavirin in Hepatitis C Genotype 1 Nonresponders treatment 2 / 3 completed NCT00664625
A Single Ascending Dose Study of BMS-791325 in HCV Infected Subjects treatment 1 / 2 completed NCT03246048
Long Term Follow-up of Hepatitis C Cured Patients No drug interventions Not Available Not Available completed NCT00526448
Phase IV Study to Evaluate the Efficacy/Safety to Extend Treatment and High Dose of Ribavirin in co-Infected Patients treatment 4 unknown_status NCT00983957
Study to Assess the Effect of BMS-790052 on the Pharmacokinetics of Ortho Tri-Cyclen® in Healthy Female Subjects Not Available 1 completed NCT02640157
A Study Comparing Efficacy and Safety of ABT-493/ABT-530 to Sofosbuvir Dosed With Daclatasvir in Adults With HCV Genotype 3 Infection treatment 3 completed NCT00957866
Prospective Anti-Hepatitis C Virus (Anti-HCV) Trial of Peg-Interferon and Ribavirin in Subjects of First Nations, Metis and Caucasian Ethnicity supportive_care 4 completed NCT01641666
Safety and Tolerability of Boceprevir in Combination With Peginterferon Alfa-2b Plus Ribavirin for the Treatment of Vietnamese Subjects With Chronic Hepatitis C Genotype 1 (P08599) treatment 3 withdrawn NCT01655966
Vitamin D as an add-on Therapy With Pegylated Interferon and Ribavirin for Chronic Hepatitis c treatment 3 unknown_status NCT01290965
Safety, PK and Efficacy of 15 Days of SCY-635 Treatment in Hepatitis C Patients treatment 1 completed NCT00662220
High-dose Ribavirin in Treatment of Chronic Hepatitis C Genotype 1 or 4 treatment 3 terminated NCT04301882
An Observational Cohort Study of Clinical Outcomes After Antiviral Treatment of Chronic Hepatitis C Not Available Not Available unknown_status NCT02788682
Association of Vitamin D Binding Protein Polymorphisms With Response to HCV Therapy No drug interventions Not Available Not Available completed NCT00680173
Peripheral Blood Mononuclear Cell (PBMC) Gene Expression in HCV Genotype 1 Patients diagnostic 4 completed NCT03462173
The Safety, Tolerability and Pharmacokinetic Study of Yimitasvir in Healthy Adults Subjects treatment 1 completed NCT01340573
Evaluating Safety and Efficacy In Hepatitis C Patients After PegIntron Pen Treatment (Study P04896) Not Available Not Available terminated NCT00187473
Natural History of Hepatitis C in Patients With Normal Liver Tests No drug interventions Not Available Not Available completed NCT00575627
Pegylated-Interferon and Ribavirin in Hepatitis C Patients With Persistently Normal Alanine Aminotransferase Levels treatment 4 unknown_status NCT01464827
ABT-450 With Ritonavir and ABT-267 and/or ABT-333 With and Without Ribavirin in Genotype 1 Hepatitis C Virus Infected Patients treatment 2 completed NCT01439776
Add Vitamin D With Standard of Care for Chronic Hepatitis C Patients No drug interventions treatment 4 completed NCT00724776
Albinterferon Alfa 2b Single Dose in Japanese Chronic Hepatitis C Patients treatment 1 completed NCT00843076
Impact of Hepatitis C Virus Variability on Steatosis No drug interventions Not Available Not Available terminated NCT00332176
A Study to Evaluate the Safety, Antiviral Effect, and Pharmacokinetics of Celgosivir in Combination With Peginterferon Alfa-2b and Ribavirin in Treatment-Naïve Patients With Chronic Hepatitis C treatment 2 unknown_status NCT00475176
S-Adenosyl Methionine (SAMe) to Treat Patients With Chronic Hepatitis C treatment 2 completed NCT00834860
Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Hepatocellular Carcinoma treatment 4 unknown_status NCT01717560
Hepatitis C Treatment in Underserved Populations No drug interventions treatment Not Available unknown_status NCT01413360
The Effect of High Dose Vitamin C on the Liver Function in Chronic Hepatitis Patients treatment 4 completed NCT01263860
A Randomized Trial of 24-Week Versus 48-Week Courses of Peginterferon Plus Ribavirin for HCV Genotype-6 Patients treatment 3 completed NCT02964091
Simplifying Hepatitis C Antiviral Therapy in Rwanda for Elsewhere in the Developing World treatment 4 completed NCT01859962
Study of PPI-668, BI 207127 and Faldaprevir, With and Without Ribavirin, in the Treatment of Chronic Hepatitis C treatment 2 completed NCT00823862
Safety Study of SD-101 (a Novel C Type Toll-like Receptor 9 (TLR9) Agonist) for the Treatment of Chronic Hepatitis C Virus (HCV) Infection treatment 1 completed NCT02593162
A Study of Faldaprevir, Ribavirin and TD-6450 in Participants With Genotype 4 Hepatitis C Virus Infection treatment 2 completed NCT03500562
Study of Daclatasvir-based Therapy in Chinese Participants With Chronic Hepatitis C (CHC) No drug interventions Not Available Not Available terminated NCT02105662
An Efficacy and Safety Study of Grazoprevir (MK-5172) + Elbasvir (MK-8742) in the Treatment of Chronic Hepatitis C Virus in Participants Who Are Co-Infected With Human Immunodeficiency Virus:C-EDGE CO-INFXN (MK-5172-061) treatment 3 completed NCT02243280
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Co-administration of ABT-493 and ABT-530 With and Without Ribavirin in Subjects With HCV Genotype 1, 4, 5, and 6 Infection treatment 2 completed NCT02202980
Efficacy and Safety of Oral Regimens for the Treatment of Chronic HCV Infection treatment 2 completed NCT00909129
Interactions of Hepatitis C Viral (HCV) Dynamics and Immune Activation in HIV Coinfected Patients During HCV Treatment basic_science Not Available completed NCT00211692
Hepatitis C Treatment Naive Genotype 1 Consensus Interferon Trial treatment 3 completed NCT01360892
Prediction of Incidence of Liver Cancer by Use of Real-time Tissue Elastography No drug interventions Not Available Not Available unknown_status NCT01453244
Pharmacogenomic Research in Korean Patients With Hepatitis C No drug interventions Not Available Not Available completed NCT00491244
Pegylated Interferon Alfa-2a Plus Low Dose Ribavirin for Treatment-Naïve Hemodialysis Patients With Chronic Hepatitis C treatment 4 completed NCT01766167
Clinical Pharmacology Study of MP-424 basic_science 1 completed NCT00629967
A Randomized Trial of 24-Week Versus 48-Week Courses of Peginterferon Plus Ribavirin for HCV Genotype-1 Patients treatment 4 completed NCT02439567
Transient Elastography to Assess Liver Fibrosis and Portal Hypertension in HCV Cirrhotic Patients Treated With New Antiviral Drugs (SPLEEN-C) No drug interventions other Not Available completed NCT00532701
Peginterferon Alfa-2a and Ribavirin for Genotype 2 Chronic Hepatitis C: Duration and Ribavirin Dose Stratified by RVR treatment 4 completed NCT02250001
Asunaprevir/Daclatasvir Safety Surveillance in Japanese Patients With Chronic Hepatitis C No drug interventions Not Available Not Available completed NCT01157104
A Drug-Drug Interaction Study Evaluating the Combination of IDX320 and IDX184 in Healthy Participants (MK-6844-002) No drug interventions treatment 1 completed NCT03020004
Efficacy and Safety of Danoprevir/r + PR 12-week Triple Therapy in Treatment-Naive, Non-Cirrhotic, G1 CHC China II treatment 2 completed NCT00408304
Prevention of Depression With Omega-3 Fatty Acids in Chronic Carriers of Hepatitis C Treated With Interferon Alpha. prevention 2 unknown_status NCT00844272
Psychoeducation Reaches HCV-infected Methadone/Buprenorphine Substituted Patients in Standard Antiviral Treatment No drug interventions treatment 4 completed NCT01056172
PegIFN Alfa-2a and RBV for 16 or 24 Weeks in Patients With Chronic Hepatitis C(CHC) 2 With Rapid Virologic Response(RVR) treatment 4 unknown_status NCT00144469
A Study of Peginterferon Alfa-2a in Combination With Ribavirin in Patients With Chronic Hepatitis C treatment 3 completed NCT00828269
Evaluation of RNA From the Liver Tissue Obtained in Patients With Chronic Hepatitis C (0000-123) No drug interventions diagnostic 1 completed NCT00735969
High-Dose Ribavirin and Peginterferon to Treat Chronic Hepatitis C Genotype 1 treatment 2 completed NCT01547312
Evaluation of Hepatic Pharmacokinetics for Grazoprevir (MK-5172) in Participants With Chronic Hepatitis C (MK-5172-022) diagnostic 1 withdrawn NCT01525212
Multiple Ascending Dose Study of BMS-929075 in Hepatitis C Virus (HCV) Infected Patients treatment 1 withdrawn NCT02118012
Evaluation of Safety, Tolerability, and Antiviral Activity of Chlorcyclizine HCl in Patients With Chronic Hepatitis C treatment 1 / 2 completed NCT00635310
Safety Profiles of Liver Biopsy in Hemodialysis Patients With Chronic Viral Hepatitis Pre-treated With Vasopressin No drug interventions Not Available Not Available unknown_status NCT01403181
Effect of Boceprevir on HCV-specific T Cell Responses Not Available Not Available completed NCT00375895
Switch From Tacrolimus to Cyclosporin in the Treatment of Recurrent Hepatitis C After Liver Transplantation treatment 3 terminated NCT01120795
Pegylated Interferon and Ribavirin in Hepatitis C Patients on Opioid Pharmacotherapy treatment 4 completed NCT01113814
Acoustic Radiation Force Impulse-Imaging in Comparison to Transient Elastography for Liver Fibrosis Staging in HCV No drug interventions diagnostic Not Available completed NCT00571714
Pilot Comparison of Standard Antiviral Therapy With and Without 12 Weeks of Betaine in Genotype 1 Naive Patients treatment Not Available withdrawn NCT03501550
Study of CDI-31244 in Combination With Sofosbuvir (SOF) and Velpatasvir (VEL) treatment 2 completed NCT00637923
Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin in Treatment-Naive Hepatitis C Patients treatment 2 completed NCT05138523
Evaluation of the Efficacy and Safety of the Fixed-dose Combination Sofosdac® 400mg/60mg in Patients With Chronic Hepatitis C (HCV) No drug interventions Not Available Not Available completed NCT00663208
A Multiple Ascending Dose Study of Daclatasvir (BMS-790052) in Hepatitis C Virus Genotype 1 Infected Subjects treatment 2 completed NCT00433108
Trial of MitoQ for Raised Liver Enzymes Due to Hepatitis C treatment 2 completed NCT01517308
24 VS 48-WEEK TREATMENT WITH PEG-IFN ALPHA-2A IN PATIENTS WITH GENOTYPE 2/3 CHRONIC HEPATITIS C treatment 3 withdrawn NCT02636608
Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Hungary No drug interventions Not Available Not Available completed NCT02371408
A Study of the Efficacy and Safety of PPI-668 (NS5A Inhibitor) Plus Sofosbuvir, With or Without Ribavirin, in Patients With Chronic Hepatitis C Genotype-4 treatment 2 / 3 unknown_status NCT01625338
Open-Label Study of Sofusbuvir+Ribavirin With or Without Peginterferon Alfa-2a in Subjects With Chronic HCV Infection Who Participated in Prior Gilead HCV Studies treatment 3 completed NCT02692703
A Study to Evaluate the Safety and Efficacy of ABT-493/ABT-530 in Adult Post-Liver or Post-Renal Transplant Recipients With Chronic Hepatitis C Virus (MAGELLAN-2) treatment 3 completed NCT01342003
HCV Genotype 1a Shows a Better Virological Response to Antiviral Therapy Than HCV Genotype 1b No drug interventions Not Available Not Available completed NCT01514890
French Cohort of Therapeutic Failure and Resistances in Patients Treated With a Protease Inhibitor (Telaprevir or Boceprevir), Pegylated Interferon and Ribavirin No drug interventions Not Available Not Available completed NCT01455090
Study to Determine the Effectiveness and Safety of a Three Drug Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Not Previously Treated With Currently Available Medications treatment 2 completed NCT00196664
Efficacy of Paroxetine in the Prevention of Depressive Syndrome in Patients With Chronic Hepatitis C Treated by PEG-Interferon Alfa Plus Ribavirin treatment 3 completed NCT00704964
Impact of Patient Support by the Medical Staff on Adherence to Therapy With PegIntron Plus Rebetol (Study P04413) Not Available Not Available completed NCT01607021
Pharmacogenomics Study on IL28B Genetic Variants in Chinese Children With Hepatitis C Virus Infection No drug interventions Not Available Not Available unknown_status NCT01704521
Viral Kinetics in HCV Clearance in Subjects With Hemophilia Not Available 1 completed NCT02115321
Study of Efficacy and Safety of Grazoprevir (MK-5172) + Elbasvir (MK-8742) in Chronic Hepatitis C Participants With Child-Pugh (CP)-B Hepatic Insufficiency (MK-5172-059) treatment 2 / 3 completed NCT00854802
A Study of Debio 025 (Alisporivir) Combined With Peg-IFNα2a and Ribavirin in Treatment naïve Chronic Hepatitis C Genotype 1 Patients treatment Not Available completed NCT02807402
Effectiveness of Paritaprevir/Ritonavir, Ombitasvir, + Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in Romania No drug interventions Not Available Not Available completed NCT00944684
High Dose Ribavirin in the Treatment of Chronic Hepatitis C treatment 2 completed NCT00630084
Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Malignancy Other Than Hepatocellular Carcinoma treatment 4 completed NCT00491179
Retreatment of Dialysis Patients With Chronic Hepatitis C With Pegylated Interferon Alfa-2a Plus Low Dose Ribavirin treatment 4 completed NCT01433887
Response to Pegylated Interferon and Ribavirin in Chinese Patients With Chronic Hepatitis C Genotypes 1 Versus 2/3 Versus 6 treatment 3 completed NCT02545387
Hepatitis C Virus in Neutrophil Granulocyte Progenitor Cells No drug interventions Not Available Not Available withdrawn NCT02971033
Ezetimibe as a Safe and Efficacious Treatment for Chronic Hepatitis C treatment 2 terminated NCT00230854
Study in Non-responder Hepatitis C Genotype 1 Patients With EMZ702, Pegylated Interferon and Ribavirin treatment 1 completed NCT03313154
Impact on QoL and Cognitive Functioning of New Antiviral Therapies in Subjects With Chronic Hepatitis HCV-related No drug interventions Not Available Not Available completed NCT00160251
Boceprevir (SCH 503034) Plus Peg-Intron, With and Without Added Ribavirin, in Patients With Chronic Hepatitis C, Genotype 1, Who Did Not Respond to Previous Treatment With Peginterferon Alfa Plus Ribavirin (Study P03659AM2)(COMPLETED) treatment 2 completed NCT02640547
Real World Evidence of the Effectiveness of Paritaprevir/Ritonavir, Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C No drug interventions Not Available Not Available completed NCT01095445
EXtended Therapy in Hepatitis C Genotype 3 Infected Patients treatment 3 terminated NCT01649245
Hansenula-derived Pegylated Interferon in Treatment of Patients With Chronic Hepatitis C No drug interventions treatment 4 unknown_status NCT01664845
Effects of Metformin, Pegylated Interferon Alpha and Ribavirin for Chronic Hepatitis C With Insulin Resistance treatment 2 / 3 unknown_status NCT00209898
Hepatitis C Treatment of Inmates No drug interventions treatment 4 terminated NCT01151397
Does 3 Months Therapy With Vitamin D + Peg + Ribavirin Improve Sustained Virologic Response (SVR) in Genotype 2, 3 Chronic Hepatitis C Patients? treatment Not Available unknown_status NCT03067883
Efficacy and Safety of Qurevo Plus Ribavirin Based Therapy for Hepatitis C With or Without Cirrhosis in Haemodialysis Patients treatment 2 unknown_status NCT00120861
Valopicitabine Alone and Together With Pegylated Interferon in Patients With Chronic Hepatitis C Who Have Failed to Respond to Standard Therapy treatment 2 completed NCT01314261
Study of ABT-267 in Treatment Naive Hepatitis C Virus (HCV) Genotype 1 Infected Subjects treatment 2 completed NCT00528528
An Open-Label Study of Telaprevir Administered Every 12 or 8 Hours in Combination With One of Two Pegylated Interferons and Ribavirin in Treatment-Naive Genotype 1 Chronic Hepatitis C Participants treatment 2 completed NCT02691728
Study to Investigate the Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Subjects With Chronic Genotype 1 and 4 HCV Infection With Autoimmune Disease No drug interventions treatment 4 unknown_status NCT00028093
Pegylated Interferon and Ribavirin to Treat Chronic Hepatitis C With and Without Kidney Disease No drug interventions treatment 4 completed NCT02243293
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Co-Administration of ABT-493 and ABT-530 With and Without RBV in Subjects With Chronic Hepatitis C Virus (HCV) Genotypes 2, 3, 4, 5 or 6 Infection No drug interventions treatment 2 / 3 completed NCT00093093
Study of Viramidine to Ribavirin in Patients With Chronic Hepatitis C Who Are Treatment Naive No drug interventions treatment 3 completed NCT01995071
A Study to Evaluate the Safety and Antiviral Effect of Multiple Doses of ABT-493 and ABT-530 in Adults With Genotype 1 Hepatitis C Virus (HCV) No drug interventions treatment 2 completed NCT00351871
Influence of Marker of Insulin Resistance Upon Hepatitis C Virus (HCV) Treatment Responses to PEG Intron and Rebetol Therapy No drug interventions treatment 4 completed NCT01783678
A Phase 3, Open-label Study to Investigate the Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2, 3 and 4 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Adults No drug interventions treatment 3 completed NCT03811678
The Tolerability and Pharmacokinetics Study of Kangdaprevir Sodium Tablet in Healthy Adult Subjects No drug interventions treatment 1 completed NCT02105688
An Efficacy and Safety Study of Grazoprevir (MK-5172) + Elbasvir (MK-8742) in the Treatment of Chronic Hepatitis C Virus (HCV) Genotype (GT)1, 4, or 6 Infection in Treatment-Naïve Participants Who Are on Opiate Substitution Therapy (MK-5172-062) No drug interventions treatment 3 completed NCT02207088
Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease No drug interventions treatment 3 completed NCT00537407
A Study of Debio 025 in Combination With PegIFN Alpha-2a and Ribavirin in Chronic HCV Patients Non-responders to Standard Treatment No drug interventions treatment 2 completed NCT02339207
First in Human Study of AL-335; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C Genotype 1 No drug interventions treatment 1 completed NCT00172809
Interferon Treatment for Patients With Chronic Hepatitis C and End Stage Renal Disease No drug interventions treatment 4 completed NCT01896609
Trial Comparing the Efficacy, Tolerability and Safety Between Three Arms in Treatment of HCV in Egyptian Population No drug interventions treatment 4 unknown_status NCT00659256
Hepatitis C Treatment and Atherosclerosis No drug interventions Not Available Not Available completed NCT01276756
Efficacy of Nitazoxanide in the Treatment of Chronic Hepatitis C Virus (HCV) No drug interventions treatment 2 / 3 completed NCT03488485
Management of Patients With Hepatitis C in a Public Health Care Setting: The Punjab Model No drug interventions health_services_research Not Available unknown_status NCT01018615
Safety, Metabolism, and Antioxidant Activity of Silymarin and Green Tea Extract in Patients With Chronic Hepatitis C No drug interventions treatment 1 completed NCT02786537
Study of Oral Treatments for Hepatitis C No drug interventions treatment 4 completed NCT03510637
"Real Life" Evaluation of Efficacy and Safety of Direct Antiviral Agents (DAAs) for the Treatment of Hepatitis C Virus in Egypt No drug interventions Not Available Not Available unknown_status NCT01457937
Boceprevir/PegIFN α-2b/Riba in HCV+ Gt1 Menopausal Women, Nonresponders to PegIFN/Riba or Treatment-naives (MEN_BOC) No drug interventions treatment 3 unknown_status NCT03887637
Real-world Effectiveness and Safety of Treatment With DAAs in Patients With CHC(Chronic Hepatitis C) No drug interventions Not Available Not Available unknown_status NCT02126137
Pilot Study of Ezetimibe for Chronic Hepatitis C Virus (HCV) Infection No drug interventions basic_science 1 unknown_status NCT03036852
Sofosbuvir/Velpatasvir in Adults With Chronic Hepatitis C Virus Infection Who Are on Dialysis for End Stage Renal Disease No drug interventions treatment 2 completed NCT00804752
Vitamin D Treatment in Patients With Chronic Hepatitis C No drug interventions Not Available Not Available unknown_status NCT04202952
The Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC110114 Tablets in HCV-infected Subjects No drug interventions treatment 1 / 2 completed NCT00759200
Safety and Efficacy of Albumin Interferon Administered Every 4 Weeks in Genotype 2/3 Hepatitis C Patients No drug interventions treatment 2 completed NCT01890200
The Effects of Adding TCM-700C on the Standard Combination Treatment for HCV Genotype 1 Patients(Phase III) No drug interventions treatment 3 withdrawn NCT00100659
PEDS-C: Pegylated Interferon +/- Ribavirin for Children With Hepatitis C No drug interventions treatment 3 completed NCT04201275
The Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC74647 in HCV-infected Subjects No drug interventions treatment 1 completed NCT01937975
The Pharmacokinetics of Grazoprevir (MK-5172) and Elbasvir (MK-8742) in Participants With Renal Insufficiency (MK-5172-050) No drug interventions treatment 1 completed NCT00028275
Gamma Interferon Therapy for Chronic Hepatitis C No drug interventions treatment 2 completed NCT00049842
Prevention of Disease Progress in Chronic Hepatitis C Patients With Liver Fibrosis (Study P02570AM2)(COMPLETED) No drug interventions treatment 3 completed NCT00687999
NIDDM and IR in Combination Therapy for CHC No drug interventions treatment Not Available completed NCT01178749
Exploration of Chronic Hepatitis C Infection Receiving 24-week Interferon-α With Ribavirin Treatments No drug interventions Not Available Not Available unknown_status NCT00962936
Safety and Tolerability Study of the Monoclonal Antibody CT-011 in Patients With Chronic Hepatitis C Genotype I Infection No drug interventions treatment 1 / 2 terminated NCT00466336
Prediction of Hepatic Fibrosis in Patients With Chronic Hepatitis C by Biochemical and Duplex Doppler Indices No drug interventions Not Available Not Available completed NCT03481036
DAA Therapy in Pediatric Patients With Chronic Hepatitis C No drug interventions treatment Not Available unknown_status NCT00336518
Continuing Treatment With Pegasys and Copegus No drug interventions treatment 3 unknown_status NCT00487318
Fluvastatin, Rosuvastatin Added to Pegylated Interferon and Ribavirin No drug interventions treatment 2 completed NCT00611819
Two Different Treatments 24 vs 48 Weeks Chronic Hepatitis C Genotypes 2 and/or 3 in co-Infected HIV-HCV No drug interventions treatment 4 unknown_status NCT00445419
Phase I Hepatitis C Vaccine Trial of Virosome-formulated Peptides No drug interventions treatment 1 completed NCT00086541
Daily-Dose Consensus Interferon and Ribavirin: Efficacy of Combined Therapy No drug interventions treatment 3 completed NCT02293941
Liver Test Study of Using JKB-122 in Hepatitis C Virus (HCV)-Positive Patients Nonresponsive to Prior Interferon Based Therapies No drug interventions treatment 2 terminated NCT03088917
'Fibrosis in the Lost Hepatitis C Population - Track, Trace and Treat' No drug interventions Not Available Not Available completed NCT02628717
Interferon/Ribavirin-Free Sofosbuvir Based Treatment (AURIC) No drug interventions Not Available Not Available completed NCT01596517
Efficacy and Effectiveness of PegInterferon and Ribavirin in Korean Patients With Chronic Hepatitis C No drug interventions treatment 4 completed NCT00446134
Taribavirin Phase 2 Dose Finding Study for the Treatment of Hepatitis C Virus (HCV) No drug interventions treatment 2 completed NCT02946034
Viekira Pak or Mavyret Treatment for Patient With Chronic Kidney Disease and Hepatitis C No drug interventions treatment 4 completed NCT00421434
Study of Nitazoxanide, Peginterferon, and Ribavirin Combination Therapies in the Treatment of Chronic Hepatitis C No drug interventions treatment 2 / 3 completed NCT00162734
Daily-Dose Consensus Interferon and Ribavirin: Efficacy of Combined Therapy No drug interventions treatment 3 completed NCT00575224
Pegasys and Copegus for Asian Patients With Treatment-naive Hepatitis C Genotypes 6, 7, 8, 9 No drug interventions treatment 4 completed NCT03723824
Grazoprevir/Elbasvir for Genotype 1b Chronic Hepatitis C After Liver or Kidney Transplantation No drug interventions treatment 4 terminated NCT00629824
Pegylated Interferon Plus Ribavirin in Treating Older Patients With Chronic Hepatitis C No drug interventions treatment 4 completed NCT00146016
Study on Chronic Hepatitis C Treatment With Interferon Alpha, Ribavirin and Amantadine in Naive Patients No drug interventions treatment 3 completed NCT00158496
Chronic Hepatitis C Treatment by Pegylated Interferon and Ribavirin in Naive Egyptian Patients (ANRS 1211) No drug interventions treatment 3 completed NCT03894696
Frequency of Anxiety and Depression in Chronic Hepatitis C Patients Recieving Direct-Acting Antiviral Agents No drug interventions Not Available Not Available unknown_status NCT01178996
Thymosin Alpha-1 in Combination With Peg-Interferon Alfa- 2a and Ribavirin for the Therapy of Chronic Hepatitis C Nonresponsive to the Combination of IFN and Ribavirin. No drug interventions treatment 3 completed NCT00230958
Study of Viramidine to Ribavirin in Patients With Chronic Hepatitis C Who Are Treatment-Naive No drug interventions treatment 3 completed NCT00120835
Valopicitabine When Administered Alone and in Combination With Interferon to Treatment-Naive Patients With Hepatitis C No drug interventions treatment 1 / 2 completed NCT00227435
Dose Escalation Study to Evaluate the Safety and Antiviral Activity of Val-mCyd in Adults With Chronic Hepatitis C No drug interventions treatment 1 / 2 completed NCT00352235
Phase I/II Trial of KRN7000 in Patients With Chronic Hepatitis C Infection No drug interventions treatment 1 / 2 completed NCT03693586
Study to Determine the Hepatitis C Virus Infection Prevalence Among Patients Attended Primarily for Vasculitis No drug interventions Not Available Not Available completed NCT00502086
Efficacy and Safety of Viusid in Patients With Hepatic Cirrhosis Secondary to Hepatitis C Virus Infection. No drug interventions treatment 3 completed NCT00418639
Study of Nitazoxanide in the Treatment of Chronic Hepatitis C No drug interventions treatment 2 completed NCT03993925
Enhancing Access to Care for Chronic Hepatitis C Infected Populations in Hong Kong No drug interventions Not Available Not Available active_not_recruiting NCT03430830
A Study to Evaluate the Pharmacokinetics and Safety of ASC16 Tablets in Healthy Volunteers in China No drug interventions treatment 1 completed NCT05895448
Treatment of HCV-Infected Recent Injection Drug Users in U.S. Liver Clinics No drug interventions treatment 4 active_not_recruiting NCT02468648
Viral Kinetics, Interferon Stimulated Genes (ISGs) and mirRNA Among Subjects Infected With Different Hepatitis C Virus Genotypes During Therapy With Sofosbuvir and GS-5816 No drug interventions treatment 2 completed NCT00968357
Proof-of-concept Study to Evaluate the Safety and Immunomodulatory Effects of SCV 07 as Monotherapy or in Combination With Ribavirin in Noncirrhotic Subjects With Chronic Hepatitis C Who Have Relapsed No drug interventions health_services_research 2 completed NCT02097966
EU: A Multicenter Compassionate Use Program of Daclatasvir (BMS-790052) in Combination With Sofosbuvir With or Without Ribavirin for the Treatment of Subjects With Chronic Hepatitis C No drug interventions Not Available Not Available no_longer_available NCT02725866
Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Participants With Chronic Hepatitis C No drug interventions Not Available Not Available completed NCT01025765
The Effects of Oral Hypoglycemic Agents on Chronic Hepatitis C Patients Receiving Peg-Intron Plus Ribavirin No drug interventions treatment 4 unknown_status NCT00876174
Effects of Genotypes on Interferon Signaling in Chronic Hepatitis C No drug interventions Not Available Not Available withdrawn NCT01438320
Q-Trial in Patients With Hepatitis C No drug interventions treatment 1 completed NCT00881582
Peginterferon Alfa-2a Plus Ribavirin Combination Treatment in Chronic Hepatitis C Post-Renal Transplant Patients No drug interventions treatment 4 completed NCT03020082
Efficacy and Safety of Danoprevir/r + PR 12week Triple Therapy in Treatment Naive Non-Cirrhotic G1 CHC China III No drug interventions treatment 3 completed NCT01678131
Evaluating Fine Needle Aspiration to Measure Hepatic Vaniprevir (MK-7009) Concentrations in Participants With Chronic Hepatitis C (MK-7009-048) No drug interventions diagnostic 1 completed NCT00790673
A Phase 1/2 Study of CF102 in Patients With Chronic Hepatitis C Genotype 1 No drug interventions treatment 1 / 2 completed NCT03612973
Changes in Liver Fibrosis, Lipid Profile and Insulin Resistance in HCV Patients Who Received Antiviral Therapy No drug interventions diagnostic Not Available completed NCT01405027
Impact of Physician Directed Education on Patient Compliance With Hepatitis C Therapy No drug interventions treatment 4 completed NCT03283176
Hematologic Profile, Vit. B12 and Folic Acid in Cirrhotics Received Sofosbuvir and Daclatasvir With or Without Ribavirin No drug interventions Not Available Not Available completed NCT03188276
The Relationship Between MDSCs and NK Cells Activity of CHC Patient Treated by DAAs No drug interventions prevention 0 completed NCT00596960
Study of the Effects of Motivational Enhancement Therapy on Alcohol Use in Chronic Hepatitis C Patients No drug interventions treatment Not Available completed NCT02817594
Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin and Patient Support Program in Patients With Chronic Hepatitis C No drug interventions Not Available Not Available completed NCT01641094
Effect of Teleprevir in Triple Therapy on Intrahepatic Immunological Mechanisms No drug interventions Not Available Not Available completed NCT01509391
Keyhole Limpet Hemocyanin in Chronic Hepatitis C No drug interventions treatment Not Available completed NCT00495391
Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin for the Treatment of Hepatitis C No drug interventions treatment 2 completed NCT02512562
A Study to Evaluate the Effect of ACH-3102 and Simeprevir on AL-335 Pharmacokinetics in Healthy Volunteers No drug interventions treatment 1 completed NCT03053180
Real World Evidence of the Effectiveness of Paritaprevir/Ritonavir (r) - Ombitasvir, + Dasabuvir Without Ribavirin in Participants With Chronic Hepatitis C and Compensated Liver Cirrhosis in the Russian Federation No drug interventions Not Available Not Available completed NCT03687229
The Effect Of DAAs on miRNA-122 And Insulin Resistance In Chronic HCV Patients No drug interventions Not Available Not Available unknown_status NCT00001729
Combination Drug Therapy for Patients With Hepatitis C No drug interventions treatment 3 completed NCT01646489
Drug Interaction Study to Assess the Effect of Co-Administered Miravirsen and Telaprevir in Healthy Subjects No drug interventions treatment 1 completed NCT02581189
Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in Canada No drug interventions Not Available Not Available completed NCT00840489
Efficacy of Long-term Ribavirin in Non-responders With Chronic Hepatitis C and Advanced Fibrosis No drug interventions treatment 2 terminated NCT00519792
Phase 1b Study of Omega DUROS® in Patients With Chronic Hepatitis C Who Relapsed After Prior Treatment No drug interventions treatment 1 completed NCT01466192
Efficacy and Safety of MP-424, Peginterferon Alfa-2b and Ribavirin in Relapser Genotype 2 Hepatitis C Infected Patients No drug interventions treatment 3 completed NCT00543244
Early Prediction of Successful Treatment for Chronic Hepatitis C Virus Infection in Taiwan No drug interventions Not Available Not Available unknown_status NCT01545544
Observational Study of B-Cell Non Hodgkin Lymphomas (NHL) Associated With Hepatitis C Virus (HCV) No drug interventions Not Available Not Available unknown_status NCT04211844
Metabolic Changes in Chronic HCV Patients Receiving DAAS No drug interventions Not Available Not Available unknown_status NCT01359644
Study to Determine the Safety and Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) in Patients Who Have Previously Not Received the Standard of Care No drug interventions treatment 2 completed NCT01641640
Sofosbuvir With Peginterferon Alfa 2a and Ribavirin for 12 Weeks in Treatment-Naive Subjects With Chronic Genotype 1, 4, 5, or 6 HCV Infection No drug interventions treatment 3 completed NCT02669940
Observational, Multi-Center Study of the Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in the Russian Federation No drug interventions Not Available Not Available completed NCT01731301
A Pilot Study to Treat Patients With Chronic Hepatitis C Virus (HCV) Genotype 1 and End-Stage Renal Disease (ESRD) No drug interventions treatment 4 unknown_status NCT01441804
A Randomized Trial of 24-Week Versus 48-Week Courses of Peginterferon Plus Ribavirin for Patients With Genotype 1 Hepatitis C and IL28B CC Polymorphism No drug interventions treatment 3 unknown_status NCT02099604
Efficacy and Safety of the Combination Vitamin D With Standard of Care in Egyptian Patients With Untreated Chronic Hepatitis C No drug interventions treatment 3 withdrawn NCT01210404
Drug Interaction Study Of Filibuvir With Methadone Among Subjects On Chronic Methadone Maintenance No drug interventions treatment 1 completed NCT00556504
The Effects of Adding TCM-700C on the Standard Combination Treatment for Patients With Genotype 1 Hepatitis C Infection No drug interventions treatment 2 completed NCT00703872
HDV-Interferon in the Treatment of Chronic Hepatitis C Nonresponders and Naive Hepatitis C Patients No drug interventions treatment 2 unknown_status NCT00296972
Tolerability of Peginterferon Plus Ribavirin for Chronic Hepatitis C and HIV for Patients Receiving Antiretroviral Medication vs Not Receiving Antiretroviral Medication No drug interventions treatment 3 terminated NCT00530972
Pilot Study of Patients Chronic Hepatitis C in Co-infected HIV Patients Relapsers After Previous Therapies No drug interventions treatment 4 completed NCT04094272
Pulmonary Arterial Hypertension in Patients With Direct-Acting Antiviral Medications for Hepatitis C Virus Infection No drug interventions Not Available Not Available completed NCT00118768
A Study to Evaluate the Combination of Pegylated Interferon Alfa Plus Valopicitabine in Patients With Hepatitis C No drug interventions treatment 2 completed NCT00763568
4-Week Lead-In With Nitazoxanide Followed by 36 Weeks Nitazoxanide and Peginterferon Alfa-2a in Chronic Hepatitis C No drug interventions treatment 2 completed NCT01949168
A Pilot Study of Boceprevir for the Treatment of Genotype 6 HCV No drug interventions treatment 2 unknown_status NCT02851069
Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in Colombia No drug interventions Not Available Not Available completed NCT01577069
Predictive Factors of the Treatment Failure in Hepatitis C Virus (HCV) Infected Patients Treated With Telaprevir No drug interventions Not Available Not Available completed NCT02865369
Regression of Liver Fibrosis After Daclatasvir and Asunaprevir Treatment No drug interventions Not Available Not Available unknown_status NCT00433069
Retreatment of Chronic Hepatitis C Non-responders With Pegylated Interferon Alpha Plus Ribavirin Plus Pioglitazone No drug interventions treatment 2 completed NCT04695769
Combined Ribavirin With Sofosbuvir/Velpatasvir/Voxilaprevir in Retreatment of Chronic Hepatitis C Non-responders No drug interventions treatment 4 completed NCT01010646
Study Comparing the Tolerability and Viral Reduction of the Combination of IFN a-2b XL + Ribavirin Versus Peg IFN a-2b + Ribavirin in Patients With Chronic Hepatitis C, Genotype 1 or 4 No drug interventions treatment 2 unknown_status NCT01726946
A Phase 2 Study to Evaluate the Safety and Efficacy of VX-135 With Ribavirin in Treatment-Naïve Subjects With Chronic Hepatitis C No drug interventions treatment 2 completed NCT01226446
Efficacy of Vitamin D on Top of Pegylated Interferon and Ribavirin in Patients With Chronic Viral Hepatitis C Null-Responders No drug interventions treatment 2 completed NCT02714712
SR-BI and Antiviral Treatment Response in HCV No drug interventions Not Available Not Available completed NCT02123212
Birth-Cohort Evaluation to Advance Screening and Testing for Hepatitis C No drug interventions screening Not Available completed NCT01272310
Clinical Trial to Assess Safety and Efficacy of Combination Therapy: Hydroxychloroquine, Pegylated Interferon Alpha-2a and Ribavirin in Chronic Hepatitis C Subjects Non-responders to the Standard of Care Therapy. No drug interventions treatment 1 / 2 unknown_status NCT02569710
A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of the Combination of AL-335, Odalasvir, and Simeprevir No drug interventions treatment 2 completed NCT00780910
Efficacy and Safety of MP-424, Peginterferon Alfa-2b, and Ribavirin in Patients With Chronic Hepatitis C Who Relapsed After Previous Interferon Based Therapy No drug interventions treatment 3 completed NCT01826981
Efficacy and Safety of Sofosbuvir Containing Regimens for the Treatment of Chronic HCV Infection in Participants With Chronic Genotype 1, 2, 3, or 6 HCV Infection No drug interventions treatment 2 completed NCT03903081
The Tolerability and Pharmacokinetics Study of HEC110114 Tablets in Healthy Adult Subjects No drug interventions treatment 1 completed NCT01012895
Study to Determine the Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Who Have Previously Failed Standard of Care No drug interventions treatment 2 completed NCT03020095
Efficacy and Safety of Ravidasvir + Danoprevir/r 12-week Oral Therapy in Treatment-Naive Non Cirrhotic G1 CHC Taiwan No drug interventions treatment 2 completed NCT00298714
Effects of Losartan on Hepatic Fibrogenesis in Chronic Hepatitis C No drug interventions treatment 4 completed NCT00245414
Trial of Pegasys® in Patients With Chronic Hepatitis C No drug interventions treatment 4 completed NCT00591214
Safety and PK Study of MP-424 to Treat Chronic Hepatitis C No drug interventions Not Available 1 completed NCT04232514
Drug-drug Interaction Study Between HEC74647PA Capsule and HEC110114 Tablets in Healthy Subjects No drug interventions treatment 1 completed NCT02493855
Ombitasvir/ABT-450/Ritonavir and Dasabuvir Therapy With Low Dose Ribavirin (RBV), Full Dose RBV or RBV Add-On in Treatment Naive Genotype 1a Hepatitis C Virus Infected Adults No drug interventions treatment 2 completed NCT00209755
Plasma Ribavirin Assay During Combination Therapy for Chronic Hepatitis C No drug interventions diagnostic Not Available terminated NCT02253550
Simeprevir in Combination With Sofosbuvir in Treatment-Naïve or -Experienced Adults With Chronic Genotype 4 Hepatitis C Virus Infection No drug interventions treatment 2 completed NCT01604850
Sofosbuvir + Ribavirin for 12 or 16 Weeks in Treatment Experienced Subjects With Chronic Genotype 2 or 3 HCV Infection (FUSION) No drug interventions treatment 3 completed NCT02006823
Patient Self-management and Gene Guided Therapy for Chronic Hepatitis C No drug interventions Not Available Not Available completed NCT00971308
Multiple Dose Study In Treatment Naive Subjects Infected With Hepatitis C Virus No drug interventions treatment 1 completed NCT01464008
The Predictive Value of On-treatment Virological Response for Sustained Virological Response in Chronic Hepatitis C No drug interventions Not Available Not Available completed NCT00522808
A Study of the PK, Safety and Antiviral Activity of A-831 in HCV Carriers No drug interventions treatment 1 / 2 terminated NCT02738138
A Study to Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2) No drug interventions treatment 3 completed NCT02803138
Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin and Patient Support Program in Patients With Chronic Hepatitis C No drug interventions Not Available Not Available completed NCT00749138
Fourteen Day Safety of Low-Dose Tamoxifen in Patients With Chronic Hepatitis C Who Have Failed Standard Medical Therapy No drug interventions treatment 1 completed NCT00778843
Antioxidant and Immunomodulator Properties of Viusid in Patients With Chronic Hepatitis C No drug interventions treatment 3 completed NCT00200343
Efficacy and Safety Study of Ursodeoxycholic Acid to Treat Chronic Hepatitis C No drug interventions treatment 3 completed NCT04385407
Sofosbuvir With Ribavirin or Simeprevir With HCV GT4 Egyptian Patients treatment 2 completed NCT04391985
Sofosbuvir/Ombitasvir/Paritaprevir/ Ritonavir and Ribavirin for Hepatitis C Virus Genotype 4 Patients treatment 1 / 2 completed NCT02292719
A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir With Sofosbuvir With or Without Ribavirin in Adults With Chronic Hepatitis C Virus Infection treatment 2 completed NCT04387539
ٍٍSofosbuvir/Simeprevir/Daclatasvir/Ribavirin and HCV Genotype 4-infected Egyptian Experienced Participants treatment 1 / 2 completed NCT04387526
Sofosbuvir Plus Daclatasvir With or Without Ribavirin and Chronic HCV Genotype (GT) 4 treatment 2 / 3 completed NCT00215865
PEG-Interferon a-2b + Ribavirin for Treatment of Patients With Chronic Hepatitis C Who Have Previously Failed to Achieve a Sustained Virologic Response Following Interferon Alfa or Interferon a-2b + Ribavirin Therapy treatment 3 completed NCT01121731
A Phase I/II Clinical Trial With Interferon Alfa 5 in Treatment-Experienced Patients With Genotype-1 Chronic Hepatitis C treatment 1 / 2 completed NCT00563173
Phase I/IIa Dose Ranging CHRONVAC-C® Study in Chronic HCV Patients No drug interventions treatment 1 / 2 unknown_status NCT00294489
Methacetin Breath Test in HCV Patients With Normal and Near-Normal ALT No drug interventions Not Available Not Available unknown_status NCT01708889
Pharmacokinetic Study of BMS-914143 in Participants With Normal Renal Function and Mild, Moderate, Severe and End-stage Renal Dysfunction Not Available 1 completed NCT00851890
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Multiple Doses of ABT-333 Alone and in Combination With Pegylated Interferon (pegIFN) and Ribavirin (RBV) in Subjects With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection treatment 2 completed NCT00770198
sgp130 in Chronic Human Liver Disease No drug interventions Not Available Not Available completed NCT00606528
FGL2/Fibroleukin and Hepatitis C Virus Infection: A Predictor of Response to Antiviral Therapy No drug interventions Not Available Not Available completed NCT04382937
Ropeginterferon Alfa-2b (P1101) Phase 3 Study in Interferon Treatment-Naive Subjects With HCV Genotype 2 Infection No drug interventions treatment 3 completed NCT00255359
Safety, Tolerability and Efficacy of XTL 2125 in HCV-Infected Patients Who Are Interferon-Alpha Non-Responders or Relapsers No drug interventions treatment 1 withdrawn NCT00570336
Study of CTS-1027 in Hepatitis C Patients No drug interventions treatment 2 completed NCT02108301
Hepatitis C in Renal Transplant Recipients No drug interventions treatment 4 unknown_status NCT01080222
A Safety and Efficacy Study of the Combination of VX-222 and Telaprevir in Treatment-Naïve Subjects With Genotype 1 Chronic Hepatitis C Virus Infection No drug interventions treatment 2 terminated NCT01813266
Prospective Cohort Study: To Provide Evidence & Guidance in Hepatitis C Virus Screening, Comparing the New Birth Cohort Recommendations From the CDC, Versus Classical Traditional Strategies With Established Risk Factors No drug interventions Not Available Not Available withdrawn NCT01055821
Efficacy of the Therapeutic Vaccine TG4040 Combined With Pegylated Interferon and Ribavirin in Chronic HCV Patients No drug interventions treatment 2 completed NCT01833533
A Study to Evaluate Chronic Hepatitis C Infection in Adults With Genotype 1a Infection treatment 3 completed NCT02482077
Sofosbuvir Containing Regimens for the Treatment of Chronic HCV GT2 Infected Patients treatment 4 completed NCT01221298
A Pilot Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ABT-450 With Ritonavir (ABT-450/r) Dosed in Combination With ABT-072 and Ribavirin (RBV) treatment 2 completed NCT01854697
A Study to Evaluate the Efficacy and Safety of Three Experimental Drugs Compared With Telaprevir (a Licensed Product) in People With Hepatitis C Virus Infection Who Have Not Had Treatment Before treatment 3 completed NCT01854528
A Study to Evaluate the Efficacy and Safety of Three Experimental Drugs Compared With Telaprevir (a Licensed Product) for Treatment of Chronic Hepatitis C Infection in Treatment-experienced Adults treatment 3 completed NCT02932293
Triple Combination DAAs for Treating HCV GT1b Subjects No drug interventions treatment 2 withdrawn NCT00954993
Pharmacokinetics of Vaniprevir (MK-7009) and Hepatitis C Virus RNA Levels After Vaniprevir Treatment (MK-7009-029) treatment 1 terminated NCT01716585
A Study to Evaluate Chronic Hepatitis C Infection treatment 3 completed NCT02583685
Switching Regimen in Treating Cirrhotic HCV GT1b Subjects treatment 2 unknown_status NCT01715415
A Study to Evaluate Chronic Hepatitis C Infection in Treatment Experienced Adults treatment 3 completed NCT01194037
A Phase 1b/2a, Open-label,Randomized, Safety, Tolerability, Dose Finding, PK/PD, and Preliminary Efficacy Study of SC Hanferon™ in Combination With Ribavirin in Treatment-naïve Subjects With Genotype 1 Hepatitis C treatment 1 / 2 completed NCT01813552
To Evaluate the Effect of Ritonavir or Omeprazole on the Pharmacokinetics of Samatasvir (IDX719) in Healthy Participants (MK-1894-006) treatment 1 completed NCT01453075
Evaluating Three Grams Daily Valacyclovir in Patients With Chronic Hepatitis C and HSV-2 Infection (Phase I) treatment 1 completed NCT02023099
Study to Evaluate the Efficacy and Safety of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) in Japanese Adults With Subgenotype 1b Chronic Hepatitis C Virus (HCV) Infection treatment 3 completed NCT02486406
A Study to Evaluate Treatment of Hepatitis C Virus Infection in Pediatric Subjects treatment 2 / 3 completed NCT01813513
Study to Evaluate Drug-Drug Interaction Between IDX719 and Simeprevir in Healthy Participants (MK-1894-004) treatment 1 completed NCT01767116
A Study to Evaluate Chronic Hepatitis C Infection in Adults With Genotype 1b Infection treatment 3 completed NCT02480686
Neutrino Regimen for Treatment-experienced HCV GT1 Patients treatment 4 completed NCT01011166
Safety and Antiviral Activity of IDX184 in Combination With Pegylated Interferon and Ribavirin (MK-2355-004) treatment 2 completed NCT00682591
Evaluation of Neurocognitive Performance in Drug Substituted Patients Under Hepatitis C Therapy No drug interventions Not Available Not Available withdrawn NCT02356562
A Study of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Sofosbuvir and Ribavirin in Direct-Acting Antiviral Agent Treatment-Experienced Adults With Chronic Hepatitis C Virus Infection treatment 2 completed NCT01225380
A Study of Response-Guided Duration of Combination Therapy With GS-9190, GS-9256, Pegasys® and Copegus® in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C treatment 2 completed NCT02333292
Efficacy and Safety of Therapy Against HCV Based on Direct-acting Antivirals in Real-life Conditions Not Available Not Available completed NCT01580995
Herpes Simplex Type 1 Suppression in Hepatitis C treatment 2 completed NCT02576314
Sofosbuvir Containing Regimens for the Treatment of Chronic HCV GT3 Infected Patients treatment 3 completed NCT01704755
A Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267; (ABT-267 Also Known as Ombitasvir) and ABT-333 (Also Known as Dasabuvir) Coadministered With Ribavirin (RBV) in Hepatitis C Virus (HCV) Genotype 1-infected Adults With Compensated Cirrhosis treatment 3 completed NCT01260350
Open-Labeled Study of PSI-7977 and RBV With and Without PEG-IFN in Treatment-Naïve Patients With HCV GT2 or GT3 treatment 2 completed NCT02219503
A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis treatment 3 completed NCT01711164
The Role of FGL2-FcgammaRIIB Inhibitory Pathway in Human Viral Hepatitis No drug interventions Not Available Not Available completed NCT04318379
Therapeutic Hepatitis C Virus Vaccine No drug interventions treatment 1 unknown_status NCT01700179
Evaluation of Safety, Tolerability, and Antiviral Activity of ACH-0143102 Plus Ribavirin In Treatment-naive Hepatitis C Virus Infection Genotype 1b Participants treatment 1 completed NCT00854087
Assess the Antifibrotic Activity of Fuzheng Huayu in Chronic Hepatitis C Patients With Hepatic Fibrosis No drug interventions treatment 2 completed NCT00557583
Evaluation of Safety and Pharmacokinetics of Single Doses of VBY-376 in Healthy Adults No drug interventions Not Available 1 completed NCT01672983
A Study to Evaluate ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Japanese Adults With Chronic Hepatitis C Virus Infection treatment 2 completed NCT02473211
SOF Plus DCV in Treating Chinese Treatment-experienced HCV Patients No drug interventions treatment 2 / 3 completed NCT02578693
Follow up of IFN Vs DAAs HCV SVR (IFDACS Study) No drug interventions Not Available Not Available recruiting NCT02442271
A Study to Evaluate the Efficacy and Safety of Three Experimental Drugs in Adults With Hepatitis C Virus Infection, Who Are Either Treatment-naive or Treatment-experienced in Brazil No drug interventions treatment 3 completed NCT00723242
The Role of Dendritic Cells in Hepatitis C Infection No drug interventions basic_science Not Available completed NCT02504099
A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/r With or Without Dasabuvir and With or Without Ribavirin in Chronic Hepatitis C Virus Genotype 1 or 4 Infected Adults With Successfully Treated Early Stage Hepatocellular Carcinoma No drug interventions treatment 3 terminated NCT02065999
Surveillance for Antiviral Resistant Variants in Chronic Hepatitis C Patients No drug interventions Not Available Not Available completed NCT01563536
Study to Assess the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of ABT-267 in HCV Infected Subjects No drug interventions treatment 2 completed NCT01306617
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ABT-450 With Ritonavir (ABT-450/r) When Given Together With ABT-333 and Ribavirin (RBV) in Treatment-Naïve and Non-responder Subjects With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection No drug interventions treatment 2 completed NCT02470858
Triple DAAs Regimen in Treating Non-cirrhotic HCV GT1b Subjects No drug interventions treatment 2 completed NCT01674725
A Study to Evaluate the Safety and Effect of the Experimental Drugs ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 in Subjects With Chronic Hepatitis C No drug interventions treatment 3 completed NCT01586325
A Study of the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of JNJ-47910382 at Different Doses and Dose Regimens in Asian Genotype-1, Chronic, HCV-Infected Patients No drug interventions treatment 1 terminated NCT01866930
Efficacy and Safety Study of Pegylated Interferon Lambda-1a With Ribavirin and Daclatasvir, to Treat naïve Subjects With Chronic HCV Genotypes 1, 2, 3, and 4 Who Are Co-infected With HIV No drug interventions treatment 3 terminated NCT01651767
Study in HCV-Infected Patients to Determine the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of JNJ-47910382 No drug interventions treatment 1 terminated NCT01782495
A Study to Evaluate Chronic Hepatitis C Infection in Adult Transplant Recipients No drug interventions treatment 2 completed NCT00274495
Assessing the Efficacy and Safety of Rosiglitazone Added to Standard Therapy for Hepatitis C Genotype 1 With Fatty Liver No drug interventions treatment 4 terminated NCT02972723
Metformin Therapy in HCV Infection No drug interventions Not Available 4 completed NCT01074008
A Randomized Study to Evaluate the Safety, Tolerability and Antiviral Activity of ABT-450, ABT-333 and ABT-072 No drug interventions treatment 2 completed NCT01835938
Clinical Investigation of Erlotinib as an HCV Entry Inhibitor No drug interventions treatment 1 / 2 unknown_status NCT02555943
DAAs Treatment for Chronic HCV/HBV Co-infection Patients(DASCO) No drug interventions treatment 2 / 3 completed NCT01753570
Efficacy and Safety of MP-424, Interferon Beta (IFN Beta), and Ribavirin(RBV) in Treatment-Naïve or Having Received Interferon Based Therapy With Chronic Hepatitis C (CHC) treatment 3 completed NCT03868163
Real World Evidence of the Effectiveness and Clinical Practice Use of Glecaprevir Plus Pibrentasvir in Patients With Chronic Hepatitis C in the Russian Federation No drug interventions Not Available Not Available completed NCT01753557
Efficacy and Safety of MP-424, Peginterferon Alfa-2a (PEG-IFN Alfa-2a), and Ribavirin(RBV) in Treatment-Naïve or Relapsed Hepatitis C treatment 3 completed NCT01710501
A Study of Different Doses of Grazoprevir (MK-5172) Given With Pegylated Interferon Alfa-2b and Ribavirin to Treatment-Naïve Participants With Chronic Hepatitis C (MK-5172-038) No drug interventions treatment 2 completed NCT03063723
Dynamic Changes of Monocytes and NK Cells of CHC Patient Treated by DAAs Not Available Not Available completed NCT00842205
Role of Heme Oxygenase in the Pathogenesis of Hepatocellular Injury in Chronic Hepatitis C Virus (HCV) Infection basic_science Not Available unknown_status NCT02021656
Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination in Participants With Chronic Genotype 1 HCV Infection treatment 3 completed NCT02120300
Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination and Sofosbuvir + Ribavirin for Subjects With Chronic Hepatitis C Virus (HCV) and Inherited Bleeding Disorders treatment 2 completed NCT01975675
Efficacy and Safety of Sofosbuvir/Ledipasvir ± Ribavirin in Japanese Participants With Chronic Genotype 1 HCV Infection treatment 3 completed NCT05395416
Antaitavir Hasophate Capsules Combined With Yiqibuvir Tablets in Treatment Adult Patients With Chronic Hepatitis C No drug interventions treatment 2 / 3 unknown_status NCT01984294
Ledipasvir/Sofosbuvir Fixed-Dose Combination With Ribavirin or GS-9669 in Subjects With Chronic Genotype 1 HCV Infection treatment 2 completed NCT03540212
Clinical Pharmacokinetics of Daclatasvir/Sofosbuvir in Adolescents With Hepatitis C Virus treatment 2 / 3 recruiting NCT03458481
Phase 2 Study of Yimitasvir Phosphate Capsules treatment 2 completed NCT02074514
Safety and Efficacy of Sofosbuvir Plus Ribavirin in Treatment-Naive Adults With Chronic Genotype 1 or 3 HCV Infection treatment 3 completed NCT02010255
Ledipasvir/Sofosbuvir Fixed-Dose Combination Plus Ribavirin in Participants With Chronic HCV With Advanced Liver Disease or Post-Liver Transplant treatment 2 completed NCT02021643
Efficacy and Safety of Sofosbuvir Plus Ribavirin in Adults With Chronic HCV Infection treatment 3 completed NCT02973503
Study to Investigate the Efficacy of Elbasvir/Grazoprevir Fixed-Dose Combination for 8 Weeks in Treatment-Naïve, HCV GT1b-Infected Patients, With Non-severe Fibrosis treatment 3 completed NCT03487107
Phase 3 Study of Yimitasvir Phosphate Capsules No drug interventions treatment 3 completed NCT01938430
Ledipasvir/Sofosbuvir Fixed-Dose Combination + Ribavirin in Subjects With Chronic HCV With Advanced Liver Disease or Post-Liver Transplant No drug interventions treatment 2 completed NCT01091077
A Pilot Study of the Grapefruit Flavonoid Naringenin for HCV Infection No drug interventions treatment 1 completed NCT00794911
Quality of Life Therapy for Adults With Hepatitis C Virus and Cirrhosis Awaiting Liver Transplantation No drug interventions other Not Available completed NCT03002818
Quality of Life Measurement in Treatment Naïve Patients With Hepatitis C Virus (HCV) Genotype 1 (GT1) Suffering From Fatigue and Receiving Ombitasvir, Paritaprevir, and Ritonavir and Dasabuvir (Viekirax®/Exviera®) No drug interventions Not Available Not Available completed NCT02517528
ABT-450/Ritonavir/ ABT-267 (ABT-450/r/ABT-267) and ABT-333 Co-Administered With Ribavirin (RBV) in Treatment Naïve and Treatment Experienced Asian Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Compensated Cirrhosis No drug interventions treatment 3 completed NCT02950870
Efficacy Study to Evaluate the Effect of New Antiviral Drugs on HCV Infection. treatment 4 unknown_status NCT02723084
A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Japanese Adults With Genotype 2 Chronic Hepatitis C Virus Infection No drug interventions treatment 3 completed NCT00610597
Study of T Cell Phenotype Activation Pathway in Human Alcoholic Liver Disease No drug interventions Not Available Not Available completed NCT02945228
Drug Use-Results Survey in Participants Infected With Hepatitis C Virus Genotype 2 No drug interventions Not Available Not Available completed NCT01726517
Safety and Efficacy of LDV/SOF Fixed-Dose Combination (FDC) ± Ribavirin in HCV Genotype 1 Subjects treatment 2 completed NCT01691235
SIMpill Medication Dispensing Device in the Treatment of HCV No drug interventions Not Available Not Available withdrawn NCT01768286
Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin in Treatment-Experienced Subjects With Genotype 1 HCV Infection treatment 3 completed NCT01740791
Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Velpatasvir in Participants With Chronic HCV Infection treatment 1 completed NCT02806362
Study of Ombitasvir/Paritaprevir/Ritonavir in Japanese Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection With End Stage Renal Disease (ESRD) on Hemodialysis (HD) treatment 3 withdrawn NCT01686789
Randomized Controlled Open Label Trial of Peg Alpha 2a Interferon and Adjusted-dose of Ribavirin vs. Standard Therapy in the Treatment of Naive Chronic Hepatitis C Patients Infected With Genotype 4 treatment 4 completed NCT01581138
VX-222 + Telaprevir + Ribavirin for 12 or 16 Weeks in Treatment-Naive Subjects With Genotype 1a Hepatitis C treatment 2 completed NCT02038387
Prospective Clinical Study of the Role of the Immune Response, in Relation to Diet, in Patients Affected by Either Chronic Hepatitis C Virus (HCV) Infection or Non Alcoholic Fatty Liver Disease (NAFLD) No drug interventions treatment Not Available unknown_status NCT02707952
A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Japanese Adults With Chronic Hepatitis C Virus Infection No drug interventions treatment 3 completed NCT01516918
A Study to Evaluate the Efficacy and Safety of Quadruple Therapy (VX-222, Telaprevir,Peginterferon-Alfa-2a, Ribavirin) in Subjects With Chronic Hepatitis C With Compensated Cirrhosis No drug interventions treatment 2 completed NCT01851330
Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin for the Treatment of HCV (ION-3) No drug interventions treatment 3 completed NCT02105467
Study of Efficacy and Safety of Grazoprevir (MK-5172)/Elbasvir (MK-8742) Combination Regimen for Treatment-Naïve Participants With Chronic Hepatitis C Virus Genotypes 1, 4, and 6 (MK-5172-060) No drug interventions treatment 3 completed NCT01701401
Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination (FDC) With and Without Ribavirin for the Treatment of HCV No drug interventions treatment 3 completed NCT01852604
Samatasvir (IDX719) in Combinations With Simeprevir and/or TMC647055/Ritonavir With or Without Ribavirin for 12 Weeks in Participants With Chronic Hepatitis C Infection (MK-1894-005) No drug interventions treatment 2 completed NCT02629172
Drug Use-results Survey in Patients Infected With Hepatitis C Virus Genotype 1 No drug interventions Not Available Not Available completed